Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.9 | E74-like factor 1 |
Elf2
|
ENSMUSG00000037174.12 | E74-like factor 2 |
Etv2
|
ENSMUSG00000006311.8 | ets variant 2 |
Elf4
|
ENSMUSG00000031103.6 | E74-like factor 4 (ets domain transcription factor) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_79535425_79535590 | Elf1 | 19809 | 0.143772 | 0.76 | 1.5e-11 | Click! |
chr14_79521380_79521761 | Elf1 | 5872 | 0.177440 | 0.73 | 1.7e-10 | Click! |
chr14_79537521_79537689 | Elf1 | 21907 | 0.139494 | 0.70 | 2.5e-09 | Click! |
chr14_79515518_79515689 | Elf1 | 71 | 0.969133 | 0.65 | 7.0e-08 | Click! |
chr14_79530269_79530420 | Elf1 | 14646 | 0.153829 | 0.63 | 2.8e-07 | Click! |
chr3_51348932_51349101 | Elf2 | 8353 | 0.109726 | 0.76 | 1.2e-11 | Click! |
chr3_51333354_51333527 | Elf2 | 7121 | 0.118443 | 0.46 | 4.4e-04 | Click! |
chr3_51258160_51258311 | Elf2 | 2006 | 0.222740 | 0.34 | 1.0e-02 | Click! |
chr3_51277221_51277642 | Elf2 | 7 | 0.920802 | 0.32 | 1.7e-02 | Click! |
chr3_51340298_51341882 | Elf2 | 427 | 0.737752 | 0.28 | 4.2e-02 | Click! |
chrX_48454344_48454508 | Elf4 | 257 | 0.920396 | 0.86 | 6.6e-17 | Click! |
chrX_48439109_48439376 | Elf4 | 14927 | 0.180462 | 0.81 | 3.8e-14 | Click! |
chrX_48433633_48433860 | Elf4 | 20423 | 0.170340 | 0.79 | 5.0e-13 | Click! |
chrX_48453191_48453546 | Elf4 | 801 | 0.635436 | 0.78 | 2.0e-12 | Click! |
chrX_48424704_48424876 | Elf4 | 29379 | 0.150822 | 0.76 | 1.1e-11 | Click! |
chr7_30634710_30634935 | Etv2 | 1030 | 0.240477 | 0.34 | 1.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 86.69 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 81.30 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chrX_123721926_123722462 | 65.38 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123500550_123501093 | 62.46 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chrX_123271195_123271712 | 61.50 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr11_100938783_100940230 | 59.98 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr6_83032753_83034325 | 59.05 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr2_26139656_26141133 | 55.74 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chrX_123943434_123943951 | 54.98 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr2_129129245_129130482 | 52.50 |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
13 |
0.96 |
chr16_95990397_95991380 | 51.99 |
Psmg1 |
proteasome (prosome, macropain) assembly chaperone 1 |
2 |
0.97 |
chr11_48855844_48857180 | 51.99 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr11_117781135_117781437 | 45.92 |
Tmc6 |
transmembrane channel-like gene family 6 |
342 |
0.64 |
chr3_84581929_84583242 | 45.30 |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
40 |
0.97 |
chr17_84181102_84182153 | 44.78 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr3_65658208_65659857 | 44.52 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr9_109094576_109096217 | 44.43 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr2_167492358_167493413 | 44.28 |
Spata2 |
spermatogenesis associated 2 |
2 |
0.76 |
chr9_50616581_50617570 | 44.06 |
Nkapd1 |
NKAP domain containing 1 |
189 |
0.55 |
chr8_70609185_70610414 | 44.02 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr8_84197696_84198961 | 43.93 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr11_105125823_105126961 | 43.39 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr9_121277396_121277823 | 42.03 |
Gm34655 |
predicted gene, 34655 |
166 |
0.75 |
chr9_21615608_21616677 | 41.66 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr6_91972143_91972459 | 39.99 |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
6577 |
0.15 |
chr5_137530580_137532081 | 38.79 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr9_108569718_108570862 | 38.17 |
Dalrd3 |
DALR anticodon binding domain containing 3 |
376 |
0.53 |
chr11_98941353_98942362 | 38.08 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr11_79961869_79962916 | 37.93 |
Utp6 |
UTP6 small subunit processome component |
2 |
0.97 |
chr7_127768560_127769629 | 37.84 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr9_107982639_107983011 | 37.09 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
200 |
0.49 |
chr2_32734991_32735206 | 35.56 |
Sh2d3c |
SH2 domain containing 3C |
183 |
0.51 |
chr2_26578486_26578697 | 35.43 |
Egfl7 |
EGF-like domain 7 |
1423 |
0.23 |
chr7_75611639_75612062 | 35.40 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr9_61373312_61374646 | 35.27 |
Tle3 |
transducin-like enhancer of split 3 |
307 |
0.87 |
chr11_119912951_119914125 | 34.95 |
Chmp6 |
charged multivesicular body protein 6 |
97 |
0.95 |
chr19_45058030_45059049 | 34.60 |
Gm35867 |
predicted gene, 35867 |
302 |
0.83 |
chr6_124711627_124712957 | 34.52 |
Phb2 |
prohibitin 2 |
44 |
0.56 |
chr16_49798847_49799219 | 34.50 |
Gm15518 |
predicted gene 15518 |
163 |
0.95 |
chr8_126805357_126806196 | 34.47 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr8_33885663_33885895 | 34.37 |
Gm26978 |
predicted gene, 26978 |
32 |
0.97 |
chr8_20817574_20818579 | 34.26 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr8_84979246_84980613 | 34.19 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr17_67512657_67513016 | 34.18 |
Gm36201 |
predicted gene, 36201 |
116496 |
0.06 |
chr11_120597854_120599056 | 34.00 |
Anapc11 |
anaphase promoting complex subunit 11 |
15 |
0.55 |
chr2_170147589_170148059 | 33.84 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr7_127091121_127091448 | 33.59 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr9_21846665_21847082 | 32.84 |
Dock6 |
dedicator of cytokinesis 6 |
5743 |
0.11 |
chr8_110217481_110218281 | 32.74 |
Cmtr2 |
cap methyltransferase 2 |
108 |
0.97 |
chr11_113806939_113807399 | 32.69 |
Sdk2 |
sidekick cell adhesion molecule 2 |
3254 |
0.26 |
chr13_60897419_60897689 | 32.65 |
Ctla2b |
cytotoxic T lymphocyte-associated protein 2 beta |
107 |
0.87 |
chr8_104095738_104095964 | 32.65 |
Cdh5 |
cadherin 5 |
5774 |
0.15 |
chr11_60114297_60115906 | 32.60 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr4_140701770_140702866 | 32.53 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr5_137349031_137350198 | 32.52 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr6_115852875_115853903 | 32.45 |
Mbd4 |
methyl-CpG binding domain protein 4 |
18 |
0.55 |
chr6_29467899_29468607 | 32.40 |
Atp6v1f |
ATPase, H+ transporting, lysosomal V1 subunit F |
185 |
0.89 |
chr11_101551830_101552448 | 32.38 |
Nbr1 |
NBR1, autophagy cargo receptor |
10 |
0.69 |
chr9_32400635_32401003 | 32.09 |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
6834 |
0.18 |
chr7_122132401_122133528 | 32.09 |
Palb2 |
partner and localizer of BRCA2 |
18 |
0.54 |
chr2_156312038_156312665 | 31.98 |
Cnbd2 |
cyclic nucleotide binding domain containing 2 |
52 |
0.83 |
chr2_181487275_181488108 | 31.95 |
Abhd16b |
abhydrolase domain containing 16B |
5515 |
0.11 |
chr7_44553417_44554082 | 31.89 |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
41 |
0.92 |
chr17_14942812_14943939 | 31.84 |
1600012H06Rik |
RIKEN cDNA 1600012H06 gene |
104 |
0.64 |
chr1_64087943_64089121 | 31.80 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr2_84810833_84811663 | 31.78 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5019 |
0.11 |
chrX_101428817_101430172 | 31.59 |
Nono |
non-POU-domain-containing, octamer binding protein |
61 |
0.96 |
chr6_34610528_34610706 | 31.50 |
Cald1 |
caldesmon 1 |
11997 |
0.19 |
chr16_17345263_17345421 | 31.18 |
Gm24927 |
predicted gene, 24927 |
3330 |
0.16 |
chr13_59823073_59823589 | 30.92 |
Gm34961 |
predicted gene, 34961 |
65 |
0.66 |
chr12_24633832_24634168 | 30.90 |
Gm6969 |
predicted pseudogene 6969 |
5010 |
0.17 |
chr12_101028530_101029714 | 30.84 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr7_112299432_112300079 | 30.73 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
16274 |
0.27 |
chr17_47909349_47909983 | 30.43 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr2_26902788_26903393 | 30.34 |
Surf6 |
surfeit gene 6 |
211 |
0.83 |
chr18_69782179_69782395 | 30.34 |
Tcf4 |
transcription factor 4 |
99907 |
0.07 |
chr11_59885300_59885570 | 30.24 |
Gm12714 |
predicted gene 12714 |
12939 |
0.11 |
chr11_108424530_108425250 | 29.89 |
Cep112 |
centrosomal protein 112 |
302 |
0.86 |
chr7_4792408_4793492 | 29.80 |
Rpl28 |
ribosomal protein L28 |
40 |
0.93 |
chr3_95893729_95894624 | 29.78 |
Aph1a |
aph1 homolog A, gamma secretase subunit |
121 |
0.9 |
chr4_137478244_137478657 | 29.77 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
9647 |
0.14 |
chr16_32130295_32130491 | 29.75 |
Nrros |
negative regulator of reactive oxygen species |
17488 |
0.1 |
chr2_165884402_165885933 | 29.56 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr11_74896307_74898160 | 29.22 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr15_58140746_58142050 | 29.10 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr8_83332377_83333157 | 28.94 |
Elmod2 |
ELMO/CED-12 domain containing 2 |
281 |
0.87 |
chr6_47812781_47813882 | 28.86 |
Pdia4 |
protein disulfide isomerase associated 4 |
33 |
0.95 |
chr7_17058026_17058724 | 28.85 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
159 |
0.9 |
chrX_42067696_42069057 | 28.57 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr5_135168094_135168944 | 28.54 |
Bcl7b |
B cell CLL/lymphoma 7B |
74 |
0.95 |
chr10_117792117_117793375 | 28.43 |
Nup107 |
nucleoporin 107 |
41 |
0.97 |
chr7_29453052_29453769 | 28.43 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
52042 |
0.1 |
chr13_43480925_43481874 | 28.40 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr1_86479174_86479713 | 28.12 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr15_99332834_99333978 | 28.09 |
Fmnl3 |
formin-like 3 |
2321 |
0.16 |
chr14_21032131_21032511 | 28.07 |
Vcl |
vinculin |
10318 |
0.18 |
chr8_79638728_79640227 | 28.07 |
Otud4 |
OTU domain containing 4 |
141 |
0.96 |
chr5_115167520_115167731 | 28.02 |
Mlec |
malectin |
9446 |
0.1 |
chr4_127263680_127264160 | 28.01 |
Smim12 |
small integral membrane protein 12 |
20136 |
0.12 |
chr5_148361109_148361516 | 28.00 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
10234 |
0.23 |
chr2_152636359_152637068 | 27.93 |
Rem1 |
rad and gem related GTP binding protein 1 |
3746 |
0.1 |
chr5_137502130_137503030 | 27.90 |
Pop7 |
processing of precursor 7, ribonuclease P family, (S. cerevisiae) |
62 |
0.52 |
chr17_35879583_35880431 | 27.88 |
Dhx16 |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
182 |
0.82 |
chr8_121262895_121263071 | 27.78 |
5033426O07Rik |
RIKEN cDNA 5033426O07 gene |
59381 |
0.1 |
chr16_93603515_93604383 | 27.71 |
Setd4 |
SET domain containing 4 |
114 |
0.94 |
chr19_46455103_46455625 | 27.68 |
Sufu |
SUFU negative regulator of hedgehog signaling |
2542 |
0.23 |
chr5_75933655_75934023 | 27.63 |
Gm25374 |
predicted gene, 25374 |
24012 |
0.15 |
chr4_149445330_149446172 | 27.56 |
Rbp7 |
retinol binding protein 7, cellular |
7673 |
0.11 |
chr15_99029765_99030391 | 27.43 |
Tuba1c |
tubulin, alpha 1C |
187 |
0.88 |
chr1_130740875_130741242 | 27.39 |
Gm28857 |
predicted gene 28857 |
269 |
0.74 |
chr11_120142404_120142866 | 27.34 |
Slc38a10 |
solute carrier family 38, member 10 |
149 |
0.92 |
chr5_115522010_115522417 | 27.32 |
Pxn |
paxillin |
1908 |
0.17 |
chr16_18876300_18877282 | 27.29 |
Mrpl40 |
mitochondrial ribosomal protein L40 |
71 |
0.73 |
chr11_49713043_49713524 | 27.13 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr1_80218340_80218558 | 27.11 |
Fam124b |
family with sequence similarity 124, member B |
24 |
0.97 |
chr15_73732102_73732772 | 27.09 |
Gm22106 |
predicted gene, 22106 |
3273 |
0.2 |
chr13_43231981_43232458 | 27.06 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr4_118489750_118490166 | 27.01 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
103 |
0.94 |
chr7_100371458_100372465 | 26.95 |
Ppme1 |
protein phosphatase methylesterase 1 |
27 |
0.78 |
chr1_87626506_87626684 | 26.93 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
4921 |
0.19 |
chr11_61653094_61653390 | 26.80 |
Grap |
GRB2-related adaptor protein |
23 |
0.98 |
chr6_124919273_124920636 | 26.72 |
Ptms |
parathymosin |
149 |
0.88 |
chr18_61758967_61759164 | 26.72 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
24708 |
0.12 |
chr7_27490834_27491276 | 26.69 |
Sertad1 |
SERTA domain containing 1 |
3680 |
0.11 |
chr9_60687872_60688306 | 26.48 |
Lrrc49 |
leucine rich repeat containing 49 |
29 |
0.98 |
chr7_45017042_45018019 | 26.45 |
Rras |
related RAS viral (r-ras) oncogene |
431 |
0.52 |
chr2_85129465_85129890 | 26.45 |
Aplnr |
apelin receptor |
6548 |
0.13 |
chrX_53052410_53053563 | 26.33 |
Gm28730 |
predicted gene 28730 |
173 |
0.64 |
chr2_27540096_27540493 | 26.23 |
Gm13421 |
predicted gene 13421 |
132 |
0.76 |
chr17_56169887_56170252 | 26.21 |
Gm44397 |
predicted gene, 44397 |
2056 |
0.16 |
chr9_31253344_31253716 | 26.09 |
Gm7244 |
predicted gene 7244 |
21291 |
0.14 |
chr5_142425132_142425341 | 25.93 |
Foxk1 |
forkhead box K1 |
23736 |
0.17 |
chr5_43855901_43856053 | 25.88 |
Cd38 |
CD38 antigen |
12576 |
0.1 |
chr11_55405684_55405936 | 25.84 |
Sparc |
secreted acidic cysteine rich glycoprotein |
3645 |
0.2 |
chr6_72552548_72553107 | 25.82 |
Capg |
capping protein (actin filament), gelsolin-like |
111 |
0.94 |
chr9_64045641_64045837 | 25.73 |
Gm25606 |
predicted gene, 25606 |
2757 |
0.18 |
chr8_46845214_46845396 | 25.73 |
Gm45481 |
predicted gene 45481 |
11393 |
0.18 |
chr9_63687465_63687734 | 25.72 |
Smad3 |
SMAD family member 3 |
21052 |
0.19 |
chr19_4059281_4059805 | 25.68 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr17_59012796_59013456 | 25.63 |
Nudt12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
142 |
0.96 |
chr6_5156500_5156801 | 25.59 |
Pon1 |
paraoxonase 1 |
37113 |
0.14 |
chr2_120128702_120129052 | 25.41 |
Ehd4 |
EH-domain containing 4 |
848 |
0.58 |
chr7_80763876_80764435 | 25.38 |
Gm44649 |
predicted gene 44649 |
12310 |
0.17 |
chr11_5505810_5506157 | 25.36 |
Gm11963 |
predicted gene 11963 |
7143 |
0.14 |
chr11_19924323_19926342 | 25.29 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr8_126497512_126498658 | 25.28 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr8_71371523_71372116 | 25.24 |
Ocel1 |
occludin/ELL domain containing 1 |
473 |
0.64 |
chr11_107529395_107529646 | 25.23 |
C330019F10Rik |
RIKEN cDNA C330019F10 gene |
2300 |
0.19 |
chr2_165954964_165955142 | 25.20 |
Gm11462 |
predicted gene 11462 |
4736 |
0.15 |
chr11_106382523_106382839 | 25.17 |
Icam2 |
intercellular adhesion molecule 2 |
100 |
0.95 |
chr16_4541512_4542439 | 25.09 |
Srl |
sarcalumenin |
159 |
0.93 |
chr2_75763399_75763611 | 25.07 |
Gm13657 |
predicted gene 13657 |
13683 |
0.14 |
chr1_73072233_73072629 | 24.90 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
47862 |
0.15 |
chr15_102350239_102351186 | 24.75 |
Aaas |
achalasia, adrenocortical insufficiency, alacrimia |
17 |
0.59 |
chr5_34168983_34169988 | 24.71 |
Haus3 |
HAUS augmin-like complex, subunit 3 |
18 |
0.5 |
chr6_38533231_38533979 | 24.70 |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
103 |
0.96 |
chr6_136930773_136931096 | 24.63 |
Pde6h |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
7102 |
0.13 |
chr17_80825502_80826283 | 24.61 |
C230072F16Rik |
RIKEN cDNA C230072F16 gene |
70901 |
0.1 |
chr7_90041544_90041927 | 24.59 |
Gm44861 |
predicted gene 44861 |
962 |
0.45 |
chr11_46065406_46066070 | 24.52 |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
9680 |
0.13 |
chr4_86898772_86899092 | 24.46 |
Acer2 |
alkaline ceramidase 2 |
24518 |
0.19 |
chr14_70074487_70075571 | 24.43 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr2_30093353_30094532 | 24.39 |
Zdhhc12 |
zinc finger, DHHC domain containing 12 |
294 |
0.82 |
chr11_12036502_12038049 | 24.32 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr15_98608664_98610204 | 24.29 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr3_108562098_108562631 | 24.28 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr2_157367487_157367721 | 24.28 |
Manbal |
mannosidase, beta A, lysosomal-like |
10 |
0.97 |
chr17_23546226_23547548 | 24.26 |
6330415G19Rik |
RIKEN cDNA 6330415G19 gene |
3912 |
0.1 |
chr5_137596675_137597031 | 24.26 |
Mospd3 |
motile sperm domain containing 3 |
3838 |
0.08 |
chr6_88152237_88152433 | 24.25 |
Gm38708 |
predicted gene, 38708 |
38346 |
0.09 |
chr5_92745758_92746287 | 24.20 |
Gm20500 |
predicted gene 20500 |
9817 |
0.19 |
chr10_99268740_99269700 | 24.07 |
Gm34921 |
predicted gene, 34921 |
1226 |
0.27 |
chr7_25689001_25689947 | 24.07 |
Tgfb1 |
transforming growth factor, beta 1 |
547 |
0.58 |
chr2_92742025_92742423 | 24.07 |
Gm13816 |
predicted gene 13816 |
6 |
0.98 |
chr11_101248379_101248544 | 24.03 |
Ramp2 |
receptor (calcitonin) activity modifying protein 2 |
1368 |
0.19 |
chr7_29983352_29984044 | 23.98 |
Zfp568 |
zinc finger protein 568 |
257 |
0.84 |
chr12_13145384_13145901 | 23.98 |
Rpl21-ps2 |
ribosomal protein L21, pseudogene 2 |
4518 |
0.18 |
chr12_111007759_111007963 | 23.94 |
Gm48631 |
predicted gene, 48631 |
10541 |
0.11 |
chr4_142221224_142221954 | 23.93 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr2_33870382_33870694 | 23.90 |
Mvb12b |
multivesicular body subunit 12B |
16307 |
0.21 |
chr10_61906420_61906571 | 23.82 |
Col13a1 |
collagen, type XIII, alpha 1 |
28103 |
0.17 |
chr3_88603769_88604137 | 23.76 |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
2013 |
0.16 |
chr8_94901065_94901679 | 23.76 |
Ccdc102a |
coiled-coil domain containing 102A |
16149 |
0.1 |
chr9_108338578_108339700 | 23.72 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr5_137103357_137103516 | 23.68 |
Trim56 |
tripartite motif-containing 56 |
12771 |
0.11 |
chr19_5388578_5389191 | 23.67 |
Sart1 |
squamous cell carcinoma antigen recognized by T cells 1 |
181 |
0.72 |
chr4_135312755_135313155 | 23.66 |
Gm12982 |
predicted gene 12982 |
4985 |
0.13 |
chr19_37435496_37435986 | 23.65 |
Hhex |
hematopoietically expressed homeobox |
931 |
0.35 |
chr5_115542702_115542988 | 23.62 |
Pxn |
paxillin |
69 |
0.94 |
chr5_139388247_139388459 | 23.51 |
Gpr146 |
G protein-coupled receptor 146 |
1432 |
0.28 |
chr11_61366020_61366293 | 23.50 |
Slc47a1 |
solute carrier family 47, member 1 |
504 |
0.72 |
chr8_128387224_128387560 | 23.46 |
Nrp1 |
neuropilin 1 |
27995 |
0.2 |
chr11_30648868_30649937 | 23.43 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr10_127508848_127510720 | 23.39 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr6_48700249_48700426 | 23.32 |
Gimap6 |
GTPase, IMAP family member 6 |
5899 |
0.08 |
chr8_72295657_72296109 | 23.31 |
Gm10282 |
predicted pseudogene 10282 |
9377 |
0.11 |
chr7_80261042_80261722 | 23.27 |
Ngrn |
neugrin, neurite outgrowth associated |
162 |
0.9 |
chr3_101430437_101431033 | 23.24 |
Gm42538 |
predicted gene 42538 |
3799 |
0.2 |
chr10_7473576_7474027 | 23.23 |
Ulbp1 |
UL16 binding protein 1 |
163 |
0.96 |
chr3_84460630_84461321 | 23.23 |
Fhdc1 |
FH2 domain containing 1 |
7212 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.0 | 120.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
24.9 | 74.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
22.5 | 67.5 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
22.3 | 44.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
21.6 | 43.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
19.3 | 57.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
18.3 | 54.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
18.2 | 54.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
17.6 | 52.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
17.5 | 52.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
17.5 | 17.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
17.3 | 17.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
17.2 | 68.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
16.0 | 48.1 | GO:0050904 | diapedesis(GO:0050904) |
16.0 | 79.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
15.8 | 47.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
15.7 | 62.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
15.7 | 47.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
15.7 | 47.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
15.5 | 30.9 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
15.1 | 45.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
15.0 | 44.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
14.6 | 43.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
14.3 | 43.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
14.2 | 42.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
14.1 | 14.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
14.1 | 56.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
13.7 | 27.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
13.6 | 40.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
13.6 | 40.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
13.2 | 39.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
13.1 | 52.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
13.1 | 52.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
13.0 | 51.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
13.0 | 51.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
12.8 | 64.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
12.7 | 12.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
12.6 | 50.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
12.5 | 37.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
12.5 | 37.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
12.5 | 37.4 | GO:0002432 | granuloma formation(GO:0002432) |
12.5 | 12.5 | GO:0070384 | Harderian gland development(GO:0070384) |
12.5 | 62.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
12.5 | 24.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
12.4 | 49.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
12.3 | 24.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
12.2 | 36.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
12.2 | 48.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
12.1 | 24.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
12.1 | 36.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
11.9 | 35.7 | GO:0003166 | bundle of His development(GO:0003166) |
11.5 | 34.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
11.4 | 45.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
11.3 | 33.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
11.2 | 66.9 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
11.1 | 55.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
11.1 | 33.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
11.1 | 33.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
11.1 | 88.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
11.0 | 55.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
10.9 | 43.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
10.9 | 32.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
10.9 | 65.5 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
10.9 | 32.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
10.9 | 32.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
10.8 | 32.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
10.8 | 32.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
10.7 | 42.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
10.7 | 32.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
10.6 | 53.1 | GO:0070836 | caveola assembly(GO:0070836) |
10.6 | 21.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
10.5 | 42.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
10.5 | 31.5 | GO:0000087 | mitotic M phase(GO:0000087) |
10.4 | 41.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
10.4 | 31.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
10.4 | 20.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
10.4 | 31.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
10.4 | 20.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
10.4 | 10.4 | GO:0060319 | regulation of primitive erythrocyte differentiation(GO:0010725) primitive erythrocyte differentiation(GO:0060319) |
10.4 | 20.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
10.3 | 41.0 | GO:0007296 | vitellogenesis(GO:0007296) |
10.1 | 50.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
10.1 | 30.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
10.1 | 30.3 | GO:1902075 | cellular response to salt(GO:1902075) |
10.1 | 20.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
10.1 | 10.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
10.0 | 30.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
10.0 | 30.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
10.0 | 10.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
10.0 | 30.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
10.0 | 10.0 | GO:0035973 | aggrephagy(GO:0035973) |
9.9 | 19.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
9.8 | 19.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
9.8 | 29.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
9.8 | 29.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
9.8 | 9.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
9.7 | 136.3 | GO:0006907 | pinocytosis(GO:0006907) |
9.7 | 29.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
9.6 | 28.9 | GO:0007525 | somatic muscle development(GO:0007525) |
9.6 | 38.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
9.6 | 28.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
9.6 | 28.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
9.6 | 28.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
9.5 | 9.5 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
9.5 | 47.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
9.5 | 28.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
9.5 | 19.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
9.5 | 28.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
9.5 | 9.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
9.4 | 18.8 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
9.4 | 37.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
9.4 | 18.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
9.3 | 28.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
9.3 | 46.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
9.3 | 37.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
9.3 | 46.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
9.2 | 46.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
9.2 | 82.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
9.2 | 55.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
9.2 | 45.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
9.2 | 9.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
9.1 | 18.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
9.1 | 45.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
9.1 | 36.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
9.1 | 27.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
9.1 | 72.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
9.0 | 9.0 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
9.0 | 90.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
9.0 | 81.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
8.9 | 8.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
8.9 | 107.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
8.9 | 26.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
8.9 | 17.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
8.9 | 35.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
8.9 | 17.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
8.9 | 53.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
8.8 | 44.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
8.8 | 35.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
8.8 | 53.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
8.8 | 44.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
8.8 | 26.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
8.8 | 17.6 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
8.8 | 35.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
8.8 | 26.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
8.7 | 43.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
8.6 | 8.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
8.6 | 25.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
8.5 | 34.2 | GO:0031033 | myosin filament organization(GO:0031033) |
8.5 | 25.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
8.5 | 110.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
8.5 | 25.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
8.4 | 8.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
8.4 | 8.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
8.4 | 25.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
8.4 | 33.6 | GO:0006116 | NADH oxidation(GO:0006116) |
8.4 | 33.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
8.3 | 25.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
8.3 | 25.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
8.3 | 33.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
8.3 | 16.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
8.3 | 33.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
8.3 | 57.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
8.2 | 24.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
8.2 | 16.5 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
8.2 | 74.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
8.2 | 32.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
8.2 | 57.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
8.2 | 24.5 | GO:0008228 | opsonization(GO:0008228) |
8.1 | 24.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
8.1 | 24.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
8.1 | 8.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
8.1 | 16.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
8.1 | 32.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
8.1 | 32.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
8.1 | 64.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
8.0 | 64.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
8.0 | 24.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
8.0 | 8.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
8.0 | 31.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
8.0 | 8.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
8.0 | 23.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
7.9 | 39.7 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
7.9 | 7.9 | GO:0046618 | drug export(GO:0046618) |
7.9 | 31.6 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
7.9 | 31.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
7.9 | 55.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
7.8 | 15.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
7.8 | 46.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
7.8 | 31.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
7.7 | 15.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
7.7 | 84.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
7.7 | 77.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
7.7 | 30.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
7.7 | 15.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
7.7 | 7.7 | GO:0070627 | ferrous iron import(GO:0070627) |
7.7 | 15.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
7.7 | 15.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
7.7 | 15.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
7.7 | 38.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
7.7 | 15.3 | GO:0032439 | endosome localization(GO:0032439) |
7.6 | 15.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
7.6 | 45.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
7.6 | 30.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
7.6 | 22.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
7.6 | 22.7 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
7.6 | 45.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
7.5 | 22.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
7.5 | 15.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
7.5 | 90.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
7.5 | 7.5 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
7.5 | 7.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
7.5 | 52.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
7.4 | 37.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
7.4 | 110.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
7.4 | 88.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
7.3 | 14.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
7.3 | 14.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
7.3 | 14.6 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
7.3 | 29.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
7.3 | 36.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
7.3 | 58.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
7.3 | 14.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
7.2 | 115.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
7.2 | 14.4 | GO:0032782 | bile acid secretion(GO:0032782) |
7.2 | 115.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
7.2 | 7.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
7.2 | 14.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
7.1 | 50.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
7.1 | 14.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
7.1 | 14.2 | GO:0035483 | gastric emptying(GO:0035483) |
7.1 | 21.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
7.1 | 35.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
7.1 | 14.1 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
7.0 | 70.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
7.0 | 28.1 | GO:0018343 | protein farnesylation(GO:0018343) |
7.0 | 21.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
7.0 | 14.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
7.0 | 97.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
7.0 | 13.9 | GO:0015886 | heme transport(GO:0015886) |
6.9 | 13.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
6.9 | 13.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
6.9 | 20.8 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
6.9 | 27.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
6.9 | 13.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
6.9 | 20.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
6.9 | 48.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
6.9 | 6.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
6.9 | 54.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
6.9 | 68.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
6.9 | 20.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
6.9 | 20.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
6.8 | 34.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
6.8 | 6.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
6.8 | 88.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
6.8 | 6.8 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
6.8 | 20.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
6.8 | 20.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
6.8 | 27.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
6.8 | 13.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
6.8 | 6.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
6.8 | 13.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
6.8 | 27.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
6.8 | 33.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
6.7 | 13.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
6.7 | 6.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
6.7 | 13.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
6.7 | 40.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
6.7 | 20.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
6.7 | 20.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
6.7 | 26.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
6.7 | 73.4 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
6.7 | 53.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
6.7 | 20.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
6.7 | 20.0 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
6.6 | 13.3 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
6.6 | 26.5 | GO:0051031 | tRNA transport(GO:0051031) |
6.6 | 59.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
6.6 | 6.6 | GO:0019042 | viral latency(GO:0019042) |
6.6 | 13.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
6.6 | 26.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
6.6 | 85.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
6.6 | 6.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
6.6 | 13.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
6.5 | 26.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
6.5 | 32.7 | GO:0001842 | neural fold formation(GO:0001842) |
6.5 | 13.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
6.5 | 13.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
6.5 | 26.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
6.5 | 6.5 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
6.4 | 57.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
6.4 | 12.8 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
6.4 | 6.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
6.4 | 25.6 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
6.4 | 19.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
6.4 | 25.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
6.4 | 12.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
6.4 | 6.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
6.3 | 19.0 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
6.3 | 19.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
6.3 | 25.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
6.3 | 19.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
6.3 | 18.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
6.3 | 12.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
6.3 | 18.9 | GO:0015793 | glycerol transport(GO:0015793) |
6.3 | 18.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
6.3 | 44.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
6.3 | 31.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
6.3 | 6.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
6.3 | 31.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
6.3 | 6.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
6.3 | 43.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
6.2 | 24.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
6.2 | 31.1 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
6.2 | 12.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
6.2 | 55.7 | GO:0007097 | nuclear migration(GO:0007097) |
6.2 | 80.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
6.2 | 30.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
6.2 | 6.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
6.2 | 6.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
6.2 | 6.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
6.2 | 30.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
6.1 | 24.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
6.1 | 6.1 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
6.1 | 12.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
6.1 | 18.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
6.1 | 6.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
6.1 | 12.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
6.1 | 18.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
6.0 | 42.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
6.0 | 24.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
6.0 | 6.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
6.0 | 18.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
6.0 | 60.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
6.0 | 29.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
6.0 | 11.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
6.0 | 29.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
6.0 | 41.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
6.0 | 6.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
5.9 | 17.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
5.9 | 95.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
5.9 | 23.7 | GO:0015871 | choline transport(GO:0015871) |
5.9 | 23.6 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
5.9 | 70.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
5.9 | 5.9 | GO:0003164 | His-Purkinje system development(GO:0003164) |
5.9 | 17.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
5.9 | 70.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
5.9 | 23.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
5.8 | 23.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
5.8 | 23.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
5.8 | 23.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
5.8 | 69.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
5.8 | 52.3 | GO:0046697 | decidualization(GO:0046697) |
5.8 | 11.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
5.8 | 23.2 | GO:0009414 | response to water deprivation(GO:0009414) |
5.8 | 11.6 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
5.8 | 5.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
5.8 | 23.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
5.8 | 5.8 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
5.8 | 17.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
5.8 | 17.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
5.8 | 28.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
5.8 | 5.8 | GO:0032621 | interleukin-18 production(GO:0032621) |
5.8 | 17.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
5.8 | 11.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
5.8 | 11.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
5.7 | 5.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
5.7 | 34.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
5.7 | 17.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.7 | 17.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
5.7 | 17.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
5.7 | 17.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
5.7 | 28.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
5.7 | 28.4 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
5.7 | 11.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
5.7 | 11.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
5.7 | 56.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
5.7 | 34.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
5.6 | 16.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
5.6 | 16.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
5.6 | 44.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
5.6 | 55.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
5.6 | 22.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
5.6 | 50.2 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
5.5 | 22.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
5.5 | 49.9 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
5.5 | 16.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
5.5 | 22.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
5.5 | 5.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
5.5 | 27.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
5.5 | 16.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
5.5 | 11.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
5.5 | 21.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
5.5 | 16.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
5.5 | 5.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
5.5 | 16.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
5.5 | 49.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
5.4 | 32.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
5.4 | 21.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
5.4 | 59.2 | GO:0043248 | proteasome assembly(GO:0043248) |
5.4 | 37.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
5.4 | 5.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
5.3 | 16.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.3 | 5.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
5.3 | 5.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
5.3 | 111.9 | GO:0006301 | postreplication repair(GO:0006301) |
5.3 | 26.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
5.3 | 26.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
5.3 | 26.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
5.3 | 53.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
5.3 | 5.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
5.3 | 15.8 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
5.3 | 5.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
5.3 | 15.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
5.3 | 26.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
5.2 | 5.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
5.2 | 31.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
5.2 | 10.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
5.2 | 10.4 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
5.2 | 5.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
5.2 | 26.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
5.2 | 5.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
5.2 | 25.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
5.2 | 25.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
5.2 | 10.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
5.2 | 25.8 | GO:0018101 | protein citrullination(GO:0018101) |
5.2 | 10.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
5.2 | 10.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
5.1 | 5.1 | GO:0043622 | cortical microtubule organization(GO:0043622) |
5.1 | 46.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
5.1 | 15.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
5.1 | 61.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
5.1 | 40.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
5.1 | 15.3 | GO:0033483 | gas homeostasis(GO:0033483) |
5.1 | 91.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
5.1 | 5.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
5.1 | 66.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
5.1 | 20.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
5.1 | 5.1 | GO:0060281 | regulation of oocyte development(GO:0060281) |
5.1 | 15.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
5.0 | 15.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
5.0 | 25.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
5.0 | 5.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
5.0 | 5.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
5.0 | 14.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
5.0 | 64.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
5.0 | 10.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
5.0 | 5.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
5.0 | 19.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
5.0 | 9.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
5.0 | 24.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
5.0 | 5.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
5.0 | 24.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
5.0 | 9.9 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
4.9 | 19.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
4.9 | 19.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
4.9 | 14.8 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
4.9 | 4.9 | GO:0061724 | lipophagy(GO:0061724) |
4.9 | 14.8 | GO:0042938 | dipeptide transport(GO:0042938) |
4.9 | 4.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
4.9 | 19.7 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
4.9 | 9.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
4.9 | 19.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
4.9 | 34.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
4.9 | 19.6 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
4.9 | 68.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
4.9 | 14.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.9 | 4.9 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
4.9 | 14.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
4.9 | 49.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
4.9 | 19.6 | GO:0003091 | renal water homeostasis(GO:0003091) |
4.9 | 14.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
4.9 | 19.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
4.9 | 34.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
4.9 | 14.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
4.8 | 9.7 | GO:0002576 | platelet degranulation(GO:0002576) |
4.8 | 14.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
4.8 | 4.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
4.8 | 38.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
4.8 | 9.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
4.8 | 28.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
4.8 | 14.4 | GO:0051775 | response to redox state(GO:0051775) |
4.8 | 72.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
4.8 | 24.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
4.8 | 24.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
4.8 | 19.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
4.8 | 38.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
4.8 | 4.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
4.8 | 4.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
4.8 | 28.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
4.8 | 14.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
4.8 | 4.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
4.7 | 9.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
4.7 | 14.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
4.7 | 19.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
4.7 | 14.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
4.7 | 18.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
4.7 | 18.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
4.7 | 14.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
4.7 | 23.6 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
4.7 | 4.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
4.7 | 14.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.7 | 14.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
4.7 | 14.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
4.7 | 28.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
4.7 | 14.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
4.7 | 4.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
4.6 | 18.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
4.6 | 18.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
4.6 | 13.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
4.6 | 13.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
4.6 | 55.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
4.6 | 64.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
4.6 | 18.3 | GO:0034340 | response to type I interferon(GO:0034340) |
4.6 | 50.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
4.6 | 9.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
4.6 | 4.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
4.6 | 13.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
4.6 | 36.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
4.5 | 9.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
4.5 | 13.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
4.5 | 27.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
4.5 | 9.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
4.5 | 4.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
4.5 | 18.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
4.5 | 13.5 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
4.5 | 9.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
4.5 | 9.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
4.5 | 13.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
4.5 | 4.5 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
4.5 | 35.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
4.5 | 9.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
4.5 | 31.3 | GO:0050779 | RNA destabilization(GO:0050779) |
4.5 | 13.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
4.5 | 4.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
4.5 | 8.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
4.5 | 4.5 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
4.4 | 4.4 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
4.4 | 8.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
4.4 | 13.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
4.4 | 4.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
4.4 | 13.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
4.4 | 26.6 | GO:0032464 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
4.4 | 8.9 | GO:0035788 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
4.4 | 13.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
4.4 | 26.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
4.4 | 13.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
4.4 | 26.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
4.4 | 8.8 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
4.4 | 30.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
4.4 | 17.6 | GO:0015809 | arginine transport(GO:0015809) |
4.4 | 13.2 | GO:0045006 | DNA deamination(GO:0045006) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
4.4 | 4.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
4.4 | 13.2 | GO:0016556 | mRNA modification(GO:0016556) |
4.4 | 8.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
4.4 | 13.2 | GO:0001555 | oocyte growth(GO:0001555) |
4.4 | 8.8 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
4.4 | 13.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
4.4 | 8.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
4.4 | 26.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
4.4 | 13.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.4 | 8.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
4.4 | 52.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
4.3 | 17.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.3 | 17.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
4.3 | 13.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
4.3 | 8.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
4.3 | 13.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
4.3 | 8.6 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
4.3 | 4.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
4.3 | 12.9 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
4.3 | 4.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
4.3 | 4.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
4.3 | 8.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
4.3 | 4.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
4.3 | 21.3 | GO:0097421 | liver regeneration(GO:0097421) |
4.3 | 12.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
4.3 | 12.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
4.2 | 8.5 | GO:0006573 | valine metabolic process(GO:0006573) |
4.2 | 12.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
4.2 | 12.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
4.2 | 8.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.2 | 42.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
4.2 | 4.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
4.2 | 12.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
4.2 | 4.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
4.2 | 4.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
4.2 | 21.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
4.2 | 46.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
4.2 | 25.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
4.2 | 8.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
4.2 | 16.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
4.2 | 37.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
4.2 | 46.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
4.2 | 25.1 | GO:0051639 | actin filament network formation(GO:0051639) |
4.2 | 8.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
4.2 | 4.2 | GO:0043084 | penile erection(GO:0043084) |
4.2 | 4.2 | GO:0051593 | response to folic acid(GO:0051593) |
4.2 | 8.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
4.2 | 8.3 | GO:0002159 | desmosome assembly(GO:0002159) |
4.2 | 4.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
4.1 | 24.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
4.1 | 12.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
4.1 | 4.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
4.1 | 24.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
4.1 | 4.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
4.1 | 28.9 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
4.1 | 20.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
4.1 | 65.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
4.1 | 24.6 | GO:0042255 | ribosome assembly(GO:0042255) |
4.1 | 4.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
4.1 | 126.5 | GO:0070527 | platelet aggregation(GO:0070527) |
4.1 | 81.5 | GO:0014823 | response to activity(GO:0014823) |
4.1 | 48.8 | GO:0070266 | necroptotic process(GO:0070266) |
4.0 | 20.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
4.0 | 48.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
4.0 | 8.1 | GO:0070268 | cornification(GO:0070268) |
4.0 | 4.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
4.0 | 4.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.0 | 4.0 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
4.0 | 12.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
4.0 | 16.0 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
4.0 | 80.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
4.0 | 12.0 | GO:0051014 | actin filament severing(GO:0051014) |
4.0 | 36.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
4.0 | 23.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
4.0 | 19.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
4.0 | 31.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
4.0 | 7.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
4.0 | 4.0 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
4.0 | 11.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
3.9 | 3.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
3.9 | 55.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
3.9 | 19.7 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
3.9 | 7.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.9 | 27.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
3.9 | 27.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.9 | 7.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
3.9 | 19.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
3.9 | 11.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.9 | 19.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
3.9 | 3.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
3.9 | 35.0 | GO:0018904 | ether metabolic process(GO:0018904) |
3.9 | 11.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
3.9 | 19.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
3.9 | 7.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
3.9 | 11.6 | GO:0048539 | bone marrow development(GO:0048539) |
3.9 | 3.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
3.9 | 11.6 | GO:0060613 | fat pad development(GO:0060613) |
3.9 | 7.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
3.9 | 11.6 | GO:0009838 | abscission(GO:0009838) |
3.9 | 15.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
3.9 | 3.9 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
3.8 | 11.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
3.8 | 3.8 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
3.8 | 11.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.8 | 11.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
3.8 | 7.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
3.8 | 34.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
3.8 | 7.7 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
3.8 | 26.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
3.8 | 11.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
3.8 | 15.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
3.8 | 7.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
3.8 | 22.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
3.8 | 3.8 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
3.8 | 15.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
3.8 | 3.8 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
3.8 | 30.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
3.8 | 3.8 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
3.7 | 11.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
3.7 | 3.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
3.7 | 11.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.7 | 18.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
3.7 | 14.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
3.7 | 77.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
3.7 | 11.1 | GO:0040031 | snRNA modification(GO:0040031) |
3.7 | 11.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
3.7 | 29.5 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
3.7 | 11.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
3.7 | 14.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
3.7 | 33.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
3.7 | 18.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
3.7 | 7.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.7 | 3.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.7 | 62.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
3.7 | 21.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
3.6 | 14.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
3.6 | 58.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
3.6 | 25.5 | GO:0030575 | nuclear body organization(GO:0030575) |
3.6 | 10.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
3.6 | 7.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
3.6 | 10.9 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
3.6 | 21.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
3.6 | 10.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
3.6 | 7.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
3.6 | 28.7 | GO:0051601 | exocyst localization(GO:0051601) |
3.6 | 3.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
3.6 | 3.6 | GO:0072718 | response to cisplatin(GO:0072718) |
3.6 | 21.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
3.6 | 7.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.6 | 3.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
3.6 | 14.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
3.6 | 3.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
3.6 | 32.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
3.5 | 14.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
3.5 | 21.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
3.5 | 14.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
3.5 | 3.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
3.5 | 28.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
3.5 | 38.9 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
3.5 | 10.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.5 | 3.5 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
3.5 | 10.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
3.5 | 49.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
3.5 | 7.0 | GO:0048102 | autophagic cell death(GO:0048102) |
3.5 | 14.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
3.5 | 21.1 | GO:0006477 | protein sulfation(GO:0006477) |
3.5 | 3.5 | GO:0070318 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
3.5 | 10.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
3.5 | 52.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
3.5 | 3.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
3.5 | 7.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
3.5 | 14.0 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
3.5 | 14.0 | GO:0033572 | transferrin transport(GO:0033572) |
3.5 | 7.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
3.5 | 10.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
3.5 | 7.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.5 | 13.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
3.5 | 10.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
3.5 | 24.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
3.5 | 7.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
3.5 | 38.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
3.5 | 10.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
3.5 | 10.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
3.5 | 17.4 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
3.5 | 3.5 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
3.5 | 3.5 | GO:0080009 | mRNA methylation(GO:0080009) |
3.5 | 20.8 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
3.5 | 6.9 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
3.4 | 17.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
3.4 | 13.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
3.4 | 3.4 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
3.4 | 17.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
3.4 | 3.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
3.4 | 20.5 | GO:0048535 | lymph node development(GO:0048535) |
3.4 | 10.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
3.4 | 27.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
3.4 | 13.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
3.4 | 20.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
3.4 | 47.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
3.4 | 60.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
3.4 | 27.0 | GO:0034063 | stress granule assembly(GO:0034063) |
3.4 | 3.4 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.4 | 13.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
3.4 | 20.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
3.4 | 3.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
3.3 | 10.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
3.3 | 16.7 | GO:0016266 | O-glycan processing(GO:0016266) |
3.3 | 6.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
3.3 | 6.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
3.3 | 10.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
3.3 | 23.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
3.3 | 6.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.3 | 13.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.3 | 33.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
3.3 | 6.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
3.3 | 3.3 | GO:0060430 | lung saccule development(GO:0060430) |
3.3 | 6.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
3.3 | 6.5 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
3.3 | 13.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
3.3 | 19.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.3 | 9.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
3.3 | 26.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
3.3 | 35.8 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
3.3 | 9.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
3.3 | 13.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
3.3 | 3.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.3 | 9.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
3.3 | 16.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
3.2 | 9.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
3.2 | 22.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
3.2 | 16.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
3.2 | 12.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
3.2 | 9.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.2 | 12.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
3.2 | 16.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
3.2 | 25.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
3.2 | 16.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
3.2 | 3.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
3.2 | 6.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
3.2 | 57.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
3.2 | 22.5 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
3.2 | 3.2 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
3.2 | 9.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
3.2 | 12.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
3.2 | 9.6 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
3.2 | 9.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
3.2 | 16.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
3.2 | 12.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
3.2 | 19.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
3.2 | 25.6 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
3.2 | 12.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
3.2 | 9.6 | GO:0009597 | detection of virus(GO:0009597) |
3.2 | 12.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.2 | 3.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
3.2 | 3.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
3.2 | 6.4 | GO:0006833 | water transport(GO:0006833) |
3.2 | 15.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
3.2 | 6.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
3.2 | 44.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
3.2 | 3.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
3.2 | 22.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
3.1 | 15.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
3.1 | 6.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
3.1 | 3.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
3.1 | 6.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
3.1 | 9.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
3.1 | 15.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
3.1 | 3.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
3.1 | 3.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
3.1 | 6.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
3.1 | 3.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
3.1 | 9.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
3.1 | 15.6 | GO:0051026 | chiasma assembly(GO:0051026) |
3.1 | 28.0 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
3.1 | 3.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
3.1 | 9.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
3.1 | 24.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
3.1 | 9.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
3.1 | 9.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
3.1 | 34.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
3.1 | 12.4 | GO:0070305 | response to cGMP(GO:0070305) |
3.1 | 6.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
3.1 | 15.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
3.1 | 24.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
3.1 | 12.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
3.1 | 123.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
3.1 | 15.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
3.1 | 15.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
3.1 | 3.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
3.1 | 18.4 | GO:0002467 | germinal center formation(GO:0002467) |
3.1 | 3.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
3.1 | 3.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
3.1 | 6.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.1 | 3.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
3.0 | 12.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
3.0 | 3.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
3.0 | 6.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
3.0 | 9.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.0 | 6.1 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
3.0 | 3.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
3.0 | 3.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
3.0 | 48.5 | GO:0017144 | drug metabolic process(GO:0017144) |
3.0 | 36.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
3.0 | 12.1 | GO:0051596 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.0 | 42.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
3.0 | 12.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
3.0 | 21.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
3.0 | 18.1 | GO:0046051 | UTP metabolic process(GO:0046051) |
3.0 | 3.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
3.0 | 36.1 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
3.0 | 3.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
3.0 | 3.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
3.0 | 9.0 | GO:0051013 | microtubule severing(GO:0051013) |
3.0 | 6.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
3.0 | 18.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
3.0 | 3.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
3.0 | 12.0 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
3.0 | 3.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
3.0 | 11.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
3.0 | 8.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
3.0 | 11.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
3.0 | 14.8 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
3.0 | 5.9 | GO:0070459 | prolactin secretion(GO:0070459) |
2.9 | 8.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
2.9 | 17.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.9 | 29.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
2.9 | 17.7 | GO:0001840 | neural plate development(GO:0001840) |
2.9 | 2.9 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
2.9 | 58.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
2.9 | 5.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.9 | 8.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.9 | 5.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.9 | 14.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
2.9 | 32.1 | GO:0031648 | protein destabilization(GO:0031648) |
2.9 | 2.9 | GO:0007127 | meiosis I(GO:0007127) |
2.9 | 17.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
2.9 | 8.7 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
2.9 | 5.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
2.9 | 8.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.9 | 5.8 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
2.9 | 2.9 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
2.9 | 2.9 | GO:0003352 | regulation of cilium movement(GO:0003352) |
2.9 | 5.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
2.9 | 23.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
2.9 | 2.9 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.9 | 8.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
2.9 | 43.4 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
2.9 | 5.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
2.9 | 5.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.9 | 11.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.9 | 14.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.9 | 5.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.9 | 2.9 | GO:1902969 | mitotic DNA replication(GO:1902969) |
2.9 | 2.9 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
2.9 | 2.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
2.9 | 57.4 | GO:0043297 | apical junction assembly(GO:0043297) |
2.9 | 11.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.9 | 2.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
2.8 | 5.7 | GO:0021564 | vagus nerve development(GO:0021564) |
2.8 | 17.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
2.8 | 28.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
2.8 | 70.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
2.8 | 8.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.8 | 8.5 | GO:0045176 | apical protein localization(GO:0045176) |
2.8 | 5.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
2.8 | 25.2 | GO:0070269 | pyroptosis(GO:0070269) |
2.8 | 33.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.8 | 2.8 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
2.8 | 5.6 | GO:0001757 | somite specification(GO:0001757) |
2.8 | 28.0 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
2.8 | 25.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
2.8 | 11.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.8 | 41.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
2.8 | 14.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.8 | 8.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.8 | 5.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.8 | 2.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
2.8 | 5.6 | GO:0051383 | kinetochore organization(GO:0051383) |
2.8 | 2.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
2.8 | 8.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
2.8 | 13.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
2.7 | 5.5 | GO:0033762 | response to glucagon(GO:0033762) |
2.7 | 5.5 | GO:0003383 | apical constriction(GO:0003383) |
2.7 | 16.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.7 | 49.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
2.7 | 2.7 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
2.7 | 2.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.7 | 10.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
2.7 | 27.0 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
2.7 | 5.4 | GO:0009299 | mRNA transcription(GO:0009299) |
2.7 | 21.5 | GO:0006968 | cellular defense response(GO:0006968) |
2.7 | 69.8 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
2.7 | 13.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.7 | 10.7 | GO:0007000 | nucleolus organization(GO:0007000) |
2.7 | 5.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
2.7 | 5.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
2.7 | 5.3 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
2.7 | 2.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.7 | 5.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
2.7 | 2.7 | GO:0060631 | regulation of meiosis I(GO:0060631) |
2.7 | 5.3 | GO:0071800 | podosome assembly(GO:0071800) |
2.7 | 37.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
2.7 | 5.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.6 | 5.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
2.6 | 29.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
2.6 | 26.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
2.6 | 5.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
2.6 | 5.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
2.6 | 10.5 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
2.6 | 13.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.6 | 7.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.6 | 10.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
2.6 | 57.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
2.6 | 7.8 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
2.6 | 15.6 | GO:0032060 | bleb assembly(GO:0032060) |
2.6 | 2.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
2.6 | 10.4 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
2.6 | 7.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
2.6 | 5.2 | GO:0070254 | mucus secretion(GO:0070254) |
2.6 | 2.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.6 | 118.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
2.6 | 7.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.6 | 2.6 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
2.6 | 12.9 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
2.6 | 7.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
2.6 | 7.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.6 | 12.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
2.6 | 10.3 | GO:0015705 | iodide transport(GO:0015705) |
2.6 | 5.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.6 | 17.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
2.6 | 15.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
2.6 | 15.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
2.5 | 38.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
2.5 | 7.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
2.5 | 50.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
2.5 | 5.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.5 | 5.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
2.5 | 5.0 | GO:0001556 | oocyte maturation(GO:0001556) |
2.5 | 7.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
2.5 | 7.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
2.5 | 10.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
2.5 | 2.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.5 | 34.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
2.5 | 10.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
2.5 | 12.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
2.5 | 22.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
2.5 | 24.9 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
2.5 | 2.5 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
2.5 | 7.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
2.5 | 76.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
2.5 | 2.5 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
2.5 | 7.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
2.5 | 12.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.5 | 4.9 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.4 | 7.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
2.4 | 17.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.4 | 39.0 | GO:0060323 | head morphogenesis(GO:0060323) |
2.4 | 4.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
2.4 | 46.2 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
2.4 | 17.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
2.4 | 41.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
2.4 | 7.3 | GO:0061042 | vascular wound healing(GO:0061042) |
2.4 | 4.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
2.4 | 2.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
2.4 | 14.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.4 | 4.8 | GO:0002215 | defense response to nematode(GO:0002215) |
2.4 | 26.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
2.4 | 2.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
2.4 | 24.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
2.4 | 26.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
2.4 | 7.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.4 | 14.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.4 | 31.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
2.4 | 4.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
2.4 | 9.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
2.4 | 16.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
2.4 | 28.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
2.4 | 4.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
2.4 | 9.5 | GO:0015671 | oxygen transport(GO:0015671) |
2.4 | 7.1 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
2.4 | 16.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
2.4 | 33.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
2.4 | 30.6 | GO:0010761 | fibroblast migration(GO:0010761) |
2.3 | 54.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
2.3 | 110.3 | GO:0051028 | mRNA transport(GO:0051028) |
2.3 | 18.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
2.3 | 7.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.3 | 7.0 | GO:0015889 | cobalamin transport(GO:0015889) |
2.3 | 37.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
2.3 | 9.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
2.3 | 7.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
2.3 | 9.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
2.3 | 4.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
2.3 | 13.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
2.3 | 7.0 | GO:0015744 | succinate transport(GO:0015744) |
2.3 | 2.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.3 | 2.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
2.3 | 9.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.3 | 2.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.3 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
2.3 | 23.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
2.3 | 2.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.3 | 20.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
2.3 | 4.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
2.3 | 45.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
2.3 | 4.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.3 | 4.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.3 | 4.5 | GO:0048143 | astrocyte activation(GO:0048143) |
2.3 | 2.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.3 | 2.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.3 | 6.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.3 | 43.0 | GO:0007569 | cell aging(GO:0007569) |
2.3 | 2.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.3 | 6.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
2.2 | 11.2 | GO:0002591 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
2.2 | 11.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.2 | 15.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
2.2 | 6.7 | GO:0007144 | female meiosis I(GO:0007144) |
2.2 | 4.5 | GO:0043383 | negative T cell selection(GO:0043383) |
2.2 | 15.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.2 | 8.9 | GO:0001893 | maternal placenta development(GO:0001893) |
2.2 | 2.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
2.2 | 4.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.2 | 22.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
2.2 | 15.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
2.2 | 8.8 | GO:0009110 | vitamin biosynthetic process(GO:0009110) water-soluble vitamin biosynthetic process(GO:0042364) |
2.2 | 8.8 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
2.2 | 4.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
2.2 | 13.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
2.2 | 8.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
2.2 | 4.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.2 | 4.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
2.2 | 39.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
2.2 | 2.2 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.2 | 2.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
2.2 | 15.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
2.2 | 19.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
2.2 | 2.2 | GO:0044838 | cell quiescence(GO:0044838) |
2.2 | 2.2 | GO:0032570 | response to progesterone(GO:0032570) |
2.2 | 6.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
2.1 | 8.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
2.1 | 30.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.1 | 44.8 | GO:1905037 | autophagosome organization(GO:1905037) |
2.1 | 21.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
2.1 | 4.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
2.1 | 21.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
2.1 | 2.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
2.1 | 17.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
2.1 | 12.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
2.1 | 2.1 | GO:0097531 | mast cell migration(GO:0097531) |
2.1 | 4.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
2.1 | 12.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.1 | 4.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
2.1 | 29.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
2.1 | 37.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
2.1 | 6.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
2.1 | 8.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.1 | 6.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.1 | 4.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
2.1 | 6.3 | GO:0042501 | serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
2.1 | 22.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
2.1 | 10.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.1 | 2.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.1 | 6.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
2.1 | 18.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
2.1 | 2.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
2.1 | 2.1 | GO:0009650 | UV protection(GO:0009650) |
2.1 | 14.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
2.1 | 10.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
2.1 | 10.3 | GO:0000012 | single strand break repair(GO:0000012) |
2.1 | 4.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.0 | 4.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
2.0 | 4.1 | GO:0060068 | vagina development(GO:0060068) |
2.0 | 10.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
2.0 | 2.0 | GO:0060242 | contact inhibition(GO:0060242) |
2.0 | 6.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
2.0 | 8.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.0 | 20.4 | GO:0001706 | endoderm formation(GO:0001706) |
2.0 | 2.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
2.0 | 6.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
2.0 | 4.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.0 | 2.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.0 | 14.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
2.0 | 10.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
2.0 | 4.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
2.0 | 6.1 | GO:0050832 | defense response to fungus(GO:0050832) |
2.0 | 12.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
2.0 | 2.0 | GO:0061009 | common bile duct development(GO:0061009) |
2.0 | 4.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
2.0 | 4.0 | GO:0060056 | mammary gland involution(GO:0060056) |
2.0 | 12.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
2.0 | 4.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
2.0 | 4.0 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) positive regulation of collagen biosynthetic process(GO:0032967) |
2.0 | 8.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
2.0 | 33.8 | GO:0016573 | histone acetylation(GO:0016573) |
2.0 | 4.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.0 | 2.0 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
2.0 | 9.9 | GO:0015825 | L-serine transport(GO:0015825) |
2.0 | 9.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.0 | 2.0 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.0 | 2.0 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
2.0 | 5.9 | GO:0052548 | regulation of endopeptidase activity(GO:0052548) |
2.0 | 9.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
2.0 | 9.8 | GO:0045576 | mast cell activation(GO:0045576) |
2.0 | 9.8 | GO:0060065 | uterus development(GO:0060065) |
2.0 | 9.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
2.0 | 7.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
2.0 | 3.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
2.0 | 3.9 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.9 | 5.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.9 | 9.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.9 | 46.6 | GO:0001892 | embryonic placenta development(GO:0001892) |
1.9 | 1.9 | GO:0060324 | face development(GO:0060324) |
1.9 | 34.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.9 | 9.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.9 | 7.7 | GO:0016559 | peroxisome fission(GO:0016559) |
1.9 | 1.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.9 | 1.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.9 | 9.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.9 | 1.9 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.9 | 3.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.9 | 3.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.9 | 9.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.9 | 5.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.9 | 7.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.9 | 26.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.9 | 5.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.9 | 1.9 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.9 | 1.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
1.9 | 1.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.9 | 13.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.9 | 17.1 | GO:0006828 | manganese ion transport(GO:0006828) |
1.9 | 5.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
1.9 | 5.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.9 | 1.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.9 | 15.0 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
1.9 | 7.5 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
1.9 | 3.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.9 | 3.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.9 | 58.0 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
1.9 | 3.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.9 | 37.4 | GO:0042073 | intraciliary transport(GO:0042073) |
1.9 | 26.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.9 | 7.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.9 | 1.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.9 | 5.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.9 | 1.9 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
1.8 | 1.8 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.8 | 3.7 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.8 | 1.8 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.8 | 9.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.8 | 5.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.8 | 12.9 | GO:0016926 | protein desumoylation(GO:0016926) |
1.8 | 1.8 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.8 | 1.8 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
1.8 | 3.6 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
1.8 | 1.8 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
1.8 | 9.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
1.8 | 23.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
1.8 | 1.8 | GO:0015747 | urate transport(GO:0015747) |
1.8 | 3.6 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
1.8 | 9.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.8 | 10.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.8 | 9.0 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.8 | 1.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 5.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.8 | 14.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.8 | 10.6 | GO:0030261 | chromosome condensation(GO:0030261) |
1.8 | 7.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.8 | 49.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.8 | 8.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.8 | 1.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.8 | 1.8 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.8 | 1.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.8 | 1.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
1.8 | 1.8 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
1.7 | 24.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.7 | 3.5 | GO:0044788 | modulation by host of viral process(GO:0044788) |
1.7 | 5.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
1.7 | 6.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.7 | 6.9 | GO:0060326 | cell chemotaxis(GO:0060326) |
1.7 | 3.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.7 | 1.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.7 | 13.8 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
1.7 | 25.8 | GO:0016180 | snRNA processing(GO:0016180) |
1.7 | 6.9 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
1.7 | 25.7 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
1.7 | 5.1 | GO:0010039 | response to iron ion(GO:0010039) |
1.7 | 6.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
1.7 | 13.6 | GO:0048753 | pigment granule organization(GO:0048753) |
1.7 | 3.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
1.7 | 11.9 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.7 | 6.8 | GO:0007032 | endosome organization(GO:0007032) |
1.7 | 5.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
1.7 | 11.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.7 | 1.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.7 | 3.4 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
1.7 | 5.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
1.7 | 6.7 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.7 | 10.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.7 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.7 | 6.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.7 | 3.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
1.7 | 6.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.7 | 14.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
1.7 | 3.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.6 | 1.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.6 | 4.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.6 | 4.9 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
1.6 | 6.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.6 | 9.8 | GO:0030168 | platelet activation(GO:0030168) |
1.6 | 32.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.6 | 9.8 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
1.6 | 13.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
1.6 | 14.7 | GO:0051875 | pigment granule localization(GO:0051875) |
1.6 | 3.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.6 | 16.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.6 | 3.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.6 | 4.9 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
1.6 | 13.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.6 | 3.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.6 | 6.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.6 | 77.7 | GO:0007051 | spindle organization(GO:0007051) |
1.6 | 4.8 | GO:0034204 | lipid translocation(GO:0034204) |
1.6 | 3.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.6 | 8.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
1.6 | 9.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
1.6 | 1.6 | GO:0098754 | detoxification(GO:0098754) |
1.6 | 4.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
1.6 | 1.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.6 | 1.6 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
1.6 | 4.8 | GO:0036233 | glycine import(GO:0036233) |
1.6 | 6.4 | GO:0002347 | response to tumor cell(GO:0002347) |
1.6 | 3.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.6 | 1.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.6 | 23.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
1.6 | 7.9 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
1.6 | 28.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
1.6 | 4.7 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.6 | 11.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.6 | 1.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.6 | 1.6 | GO:0014904 | myotube cell development(GO:0014904) |
1.6 | 3.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.6 | 15.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.6 | 3.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
1.6 | 14.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.6 | 1.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.5 | 3.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.5 | 7.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.5 | 3.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.5 | 3.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.5 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.5 | 6.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.5 | 13.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.5 | 1.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
1.5 | 6.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
1.5 | 4.5 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
1.5 | 3.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
1.5 | 6.0 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
1.5 | 10.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.5 | 3.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.5 | 6.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.5 | 9.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.5 | 1.5 | GO:0098840 | protein transport along microtubule(GO:0098840) |
1.5 | 4.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.5 | 10.4 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.5 | 4.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.5 | 1.5 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
1.5 | 14.8 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
1.5 | 1.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
1.5 | 1.5 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
1.5 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.5 | 1.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.5 | 1.5 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.5 | 7.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
1.5 | 2.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.5 | 7.3 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
1.4 | 7.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.4 | 1.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.4 | 8.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.4 | 20.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.4 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.4 | 2.9 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
1.4 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.4 | 4.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.4 | 1.4 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
1.4 | 2.8 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
1.4 | 1.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.4 | 29.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.4 | 2.8 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.4 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.4 | 2.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.4 | 18.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.4 | 1.4 | GO:0021612 | facial nerve structural organization(GO:0021612) |
1.4 | 1.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.4 | 6.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.4 | 2.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.4 | 1.4 | GO:0001562 | response to protozoan(GO:0001562) |
1.4 | 10.9 | GO:0070166 | enamel mineralization(GO:0070166) |
1.4 | 8.1 | GO:0007041 | lysosomal transport(GO:0007041) |
1.4 | 1.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.3 | 41.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
1.3 | 5.4 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
1.3 | 21.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.3 | 22.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.3 | 13.4 | GO:0032355 | response to estradiol(GO:0032355) |
1.3 | 10.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.3 | 2.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
1.3 | 5.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.3 | 2.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.3 | 4.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.3 | 2.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.3 | 1.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.3 | 25.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.3 | 2.6 | GO:0043255 | regulation of carbohydrate biosynthetic process(GO:0043255) |
1.3 | 9.2 | GO:0006476 | protein deacetylation(GO:0006476) |
1.3 | 2.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.3 | 1.3 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
1.3 | 2.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
1.3 | 10.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
1.3 | 35.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.3 | 3.9 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
1.3 | 3.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.3 | 14.2 | GO:0051591 | response to cAMP(GO:0051591) |
1.3 | 2.6 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
1.3 | 1.3 | GO:0048478 | replication fork protection(GO:0048478) |
1.3 | 2.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.3 | 5.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.3 | 9.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.3 | 5.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.3 | 3.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.3 | 3.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.3 | 31.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
1.3 | 7.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.3 | 1.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.3 | 7.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.3 | 1.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
1.3 | 5.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 2.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
1.3 | 2.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.3 | 2.5 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
1.3 | 43.9 | GO:0009060 | aerobic respiration(GO:0009060) |
1.2 | 5.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
1.2 | 3.7 | GO:0048254 | snoRNA localization(GO:0048254) |
1.2 | 1.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
1.2 | 7.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.2 | 2.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.2 | 11.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
1.2 | 8.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
1.2 | 28.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.2 | 1.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.2 | 6.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.2 | 1.2 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
1.2 | 15.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
1.2 | 8.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.2 | 2.4 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
1.2 | 3.6 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
1.2 | 1.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.2 | 11.9 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
1.2 | 8.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.2 | 3.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.2 | 2.4 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
1.2 | 1.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
1.2 | 1.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.2 | 4.7 | GO:0046415 | urate metabolic process(GO:0046415) |
1.2 | 2.4 | GO:0015074 | DNA integration(GO:0015074) |
1.2 | 1.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.2 | 7.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.2 | 5.9 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
1.2 | 1.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.2 | 4.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.2 | 1.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.2 | 10.5 | GO:0045116 | protein neddylation(GO:0045116) |
1.2 | 1.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.2 | 1.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
1.2 | 20.9 | GO:0015914 | phospholipid transport(GO:0015914) |
1.2 | 69.1 | GO:0042060 | wound healing(GO:0042060) |
1.2 | 3.5 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.1 | 62.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.1 | 1.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.1 | 3.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.1 | 1.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.1 | 1.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.1 | 1.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.1 | 34.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.1 | 3.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.1 | 4.5 | GO:0071467 | cellular response to pH(GO:0071467) |
1.1 | 234.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
1.1 | 3.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 3.3 | GO:0048599 | oocyte development(GO:0048599) |
1.1 | 2.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.1 | 9.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.1 | 10.9 | GO:0061515 | myeloid cell development(GO:0061515) |
1.1 | 3.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.1 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.1 | 3.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.1 | 8.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.1 | 1.1 | GO:0015755 | fructose transport(GO:0015755) |
1.1 | 3.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.1 | 3.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
1.1 | 2.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
1.1 | 7.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
1.1 | 3.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
1.1 | 3.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.0 | 2.1 | GO:0010225 | response to UV-C(GO:0010225) |
1.0 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 2.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.0 | 11.4 | GO:0008272 | sulfate transport(GO:0008272) |
1.0 | 31.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.0 | 21.7 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.0 | 2.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.0 | 2.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.0 | 1.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.0 | 11.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.0 | 31.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
1.0 | 3.0 | GO:0042116 | macrophage activation(GO:0042116) |
1.0 | 10.1 | GO:1901998 | toxin transport(GO:1901998) |
1.0 | 9.1 | GO:0001890 | placenta development(GO:0001890) |
1.0 | 1.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
1.0 | 2.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.0 | 5.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.0 | 76.3 | GO:0051607 | defense response to virus(GO:0051607) |
1.0 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
1.0 | 3.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.0 | 29.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.0 | 3.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 2.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.0 | 15.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
1.0 | 17.7 | GO:0007030 | Golgi organization(GO:0007030) |
1.0 | 2.9 | GO:0007379 | segment specification(GO:0007379) |
1.0 | 1.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.0 | 3.9 | GO:0043627 | response to estrogen(GO:0043627) |
1.0 | 6.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
1.0 | 3.9 | GO:0070206 | protein trimerization(GO:0070206) |
1.0 | 10.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.0 | 1.9 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
1.0 | 4.8 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
1.0 | 2.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.0 | 7.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
1.0 | 2.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.0 | 1.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.9 | 0.9 | GO:0022403 | cell cycle phase(GO:0022403) |
0.9 | 0.9 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.9 | 7.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.9 | 0.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.9 | 1.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.9 | 2.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.9 | 37.3 | GO:1901568 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.9 | 162.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.9 | 7.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.9 | 3.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.9 | 1.8 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.9 | 1.8 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.9 | 14.6 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.9 | 2.7 | GO:0009268 | response to pH(GO:0009268) |
0.9 | 0.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.9 | 0.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 0.9 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.9 | 5.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.9 | 1.8 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.9 | 11.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.9 | 0.9 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.9 | 2.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 15.2 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.9 | 9.8 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.9 | 6.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.9 | 17.7 | GO:0001824 | blastocyst development(GO:0001824) |
0.9 | 22.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.9 | 0.9 | GO:0007140 | male meiosis(GO:0007140) |
0.9 | 4.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.9 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 4.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.9 | 5.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.9 | 6.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.9 | 3.4 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.9 | 14.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.9 | 6.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.9 | 3.4 | GO:0015893 | drug transport(GO:0015893) |
0.9 | 4.3 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.8 | 6.8 | GO:0051923 | sulfation(GO:0051923) |
0.8 | 54.1 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.8 | 2.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.8 | 8.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.8 | 0.8 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.8 | 2.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.8 | 0.8 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.8 | 0.8 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.8 | 5.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.8 | 0.8 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.8 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 2.4 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.8 | 9.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.8 | 5.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.8 | 5.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.8 | 3.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.8 | 0.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.8 | 0.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 5.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.8 | 2.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.8 | 2.3 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.8 | 16.0 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.8 | 3.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.7 | 3.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.7 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.7 | 1.5 | GO:0007099 | centriole replication(GO:0007099) |
0.7 | 4.5 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.7 | 2.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.7 | 6.6 | GO:0035690 | cellular response to drug(GO:0035690) |
0.7 | 5.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.7 | 2.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.7 | 12.1 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.7 | 0.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.7 | 7.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.7 | 1.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.7 | 13.3 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.7 | 2.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.7 | 5.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.7 | 2.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.7 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 1.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.7 | 1.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 0.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.7 | 0.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.7 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 2.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.7 | 1.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.7 | 2.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.6 | 1.3 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.6 | 1.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.6 | 1.3 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.6 | 1.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.6 | 4.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.6 | 0.6 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.6 | 1.9 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.6 | 3.0 | GO:0048538 | thymus development(GO:0048538) |
0.6 | 5.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.6 | 1.2 | GO:0009624 | response to nematode(GO:0009624) |
0.6 | 1.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.6 | 7.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.6 | 25.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.6 | 0.6 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.6 | 0.6 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.6 | 1.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 3.5 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.6 | 0.6 | GO:0045851 | pH reduction(GO:0045851) |
0.6 | 1.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.6 | 3.4 | GO:0015992 | proton transport(GO:0015992) |
0.6 | 6.2 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.6 | 15.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.6 | 5.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 11.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.5 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 103.4 | GO:0007283 | spermatogenesis(GO:0007283) |
0.5 | 1.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.5 | 0.5 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.5 | 1.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 1.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.5 | 0.5 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.5 | 0.5 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.5 | 10.7 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.5 | 6.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 0.5 | GO:0034969 | histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.5 | 2.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 0.5 | GO:0051132 | NK T cell activation(GO:0051132) |
0.5 | 1.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.5 | 0.5 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 0.9 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.5 | 3.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.5 | 2.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.5 | 4.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 1.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.5 | 0.9 | GO:0034505 | tooth mineralization(GO:0034505) |
0.5 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 5.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.5 | 1.4 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.4 | 1.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.4 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.4 | 0.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.4 | 0.4 | GO:0070988 | demethylation(GO:0070988) |
0.4 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.4 | 7.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 2.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.4 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 0.4 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.4 | 1.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.4 | 3.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 2.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.4 | 0.4 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.4 | 2.7 | GO:0048747 | muscle fiber development(GO:0048747) |
0.4 | 0.8 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.4 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.4 | 1.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.4 | 1.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.9 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 12.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.4 | 1.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.3 | 0.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.3 | 4.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 11.0 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 1.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 0.3 | GO:0070542 | response to fatty acid(GO:0070542) |
0.3 | 0.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.6 | GO:1901616 | organic hydroxy compound catabolic process(GO:1901616) |
0.3 | 0.9 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 6.8 | GO:0009636 | response to toxic substance(GO:0009636) |
0.3 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.3 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.3 | 1.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 1.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.3 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.3 | 0.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 2.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 56.2 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.5 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.2 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.2 | 0.2 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.2 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 2.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 12.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 2.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 0.7 | GO:0019218 | regulation of steroid metabolic process(GO:0019218) |
0.2 | 2.8 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 1.5 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.1 | 1.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 9.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.0 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.1 | 0.3 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.9 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
0.1 | 0.2 | GO:0045924 | regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
0.1 | 0.7 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
0.1 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.1 | GO:1905207 | regulation of cardiocyte differentiation(GO:1905207) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 7.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 10.8 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 31.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.1 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.0 | 60.1 | GO:0097443 | sorting endosome(GO:0097443) |
16.4 | 65.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
15.5 | 31.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
15.1 | 45.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
14.6 | 43.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
13.8 | 27.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
12.8 | 38.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
12.4 | 62.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
12.4 | 24.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
12.2 | 12.2 | GO:0005686 | U2 snRNP(GO:0005686) |
11.8 | 59.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
11.4 | 45.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
11.3 | 11.3 | GO:0030175 | filopodium(GO:0030175) |
11.0 | 32.9 | GO:0097413 | Lewy body(GO:0097413) |
10.7 | 53.6 | GO:0005638 | lamin filament(GO:0005638) |
10.7 | 42.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
10.7 | 53.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
10.4 | 41.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
10.2 | 30.6 | GO:0097513 | myosin II filament(GO:0097513) |
10.1 | 20.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
10.0 | 10.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
10.0 | 30.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
10.0 | 79.8 | GO:0005861 | troponin complex(GO:0005861) |
10.0 | 79.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
9.6 | 28.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
9.5 | 38.2 | GO:0072487 | MSL complex(GO:0072487) |
9.5 | 9.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
9.5 | 19.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
9.3 | 83.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
9.1 | 45.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
9.0 | 27.1 | GO:0098552 | side of membrane(GO:0098552) |
8.8 | 61.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
8.8 | 17.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
8.6 | 60.0 | GO:0042382 | paraspeckles(GO:0042382) |
8.6 | 8.6 | GO:1990423 | RZZ complex(GO:1990423) |
8.5 | 68.2 | GO:0030056 | hemidesmosome(GO:0030056) |
8.5 | 33.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
8.4 | 33.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
8.4 | 33.7 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
8.4 | 33.6 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
8.4 | 33.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
8.1 | 40.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
7.9 | 23.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
7.9 | 55.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
7.9 | 15.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
7.8 | 86.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
7.8 | 70.4 | GO:0016600 | flotillin complex(GO:0016600) |
7.8 | 70.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
7.8 | 23.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
7.7 | 38.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
7.7 | 199.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
7.7 | 38.3 | GO:0030870 | Mre11 complex(GO:0030870) |
7.4 | 52.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
7.4 | 44.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
7.4 | 44.5 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
7.4 | 29.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
7.4 | 36.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
7.3 | 29.3 | GO:0000322 | storage vacuole(GO:0000322) |
7.3 | 29.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
7.1 | 7.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
7.0 | 21.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
7.0 | 42.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
6.8 | 27.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
6.8 | 20.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
6.7 | 20.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
6.7 | 20.1 | GO:0030027 | lamellipodium(GO:0030027) |
6.7 | 33.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
6.6 | 52.9 | GO:0001650 | fibrillar center(GO:0001650) |
6.6 | 39.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
6.6 | 59.0 | GO:0070938 | contractile ring(GO:0070938) |
6.5 | 32.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
6.5 | 19.5 | GO:0043293 | apoptosome(GO:0043293) |
6.5 | 19.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
6.5 | 39.0 | GO:0031209 | SCAR complex(GO:0031209) |
6.5 | 19.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
6.4 | 19.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
6.4 | 354.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
6.4 | 12.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
6.4 | 275.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
6.4 | 38.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
6.4 | 6.4 | GO:0016939 | kinesin II complex(GO:0016939) |
6.4 | 19.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
6.3 | 44.3 | GO:0031931 | TORC1 complex(GO:0031931) |
6.3 | 56.9 | GO:0042641 | actomyosin(GO:0042641) |
6.3 | 18.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
6.2 | 124.4 | GO:0008305 | integrin complex(GO:0008305) |
6.2 | 55.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
6.2 | 18.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
6.1 | 18.4 | GO:0097452 | GAIT complex(GO:0097452) |
6.1 | 6.1 | GO:0031523 | Myb complex(GO:0031523) |
6.1 | 36.6 | GO:0001739 | sex chromatin(GO:0001739) |
6.1 | 73.1 | GO:0031528 | microvillus membrane(GO:0031528) |
6.1 | 24.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
6.0 | 18.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
5.9 | 35.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
5.9 | 350.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
5.9 | 258.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
5.9 | 35.2 | GO:0005818 | aster(GO:0005818) |
5.9 | 17.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
5.9 | 23.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
5.8 | 186.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
5.7 | 377.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
5.7 | 68.6 | GO:0001891 | phagocytic cup(GO:0001891) |
5.7 | 51.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
5.6 | 45.1 | GO:0032982 | myosin filament(GO:0032982) |
5.6 | 44.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
5.6 | 33.4 | GO:0042629 | mast cell granule(GO:0042629) |
5.5 | 22.1 | GO:0042583 | chromaffin granule(GO:0042583) |
5.5 | 49.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
5.5 | 16.5 | GO:0005642 | annulate lamellae(GO:0005642) |
5.5 | 5.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
5.5 | 32.8 | GO:0001652 | granular component(GO:0001652) |
5.3 | 16.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
5.3 | 21.3 | GO:0000125 | PCAF complex(GO:0000125) |
5.3 | 158.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
5.2 | 67.9 | GO:0036038 | MKS complex(GO:0036038) |
5.2 | 15.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
5.2 | 31.0 | GO:0090543 | Flemming body(GO:0090543) |
5.1 | 15.4 | GO:0030689 | Noc complex(GO:0030689) |
5.1 | 5.1 | GO:0000791 | euchromatin(GO:0000791) |
5.1 | 5.1 | GO:0061574 | ASAP complex(GO:0061574) |
5.1 | 81.5 | GO:0005682 | U5 snRNP(GO:0005682) |
5.0 | 15.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
5.0 | 35.2 | GO:0035102 | PRC1 complex(GO:0035102) |
5.0 | 134.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
4.9 | 29.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
4.9 | 14.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.9 | 112.1 | GO:0031519 | PcG protein complex(GO:0031519) |
4.8 | 4.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
4.8 | 24.2 | GO:0005827 | polar microtubule(GO:0005827) |
4.8 | 19.3 | GO:0000938 | GARP complex(GO:0000938) |
4.8 | 9.6 | GO:1990246 | uniplex complex(GO:1990246) |
4.8 | 9.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
4.8 | 43.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
4.8 | 33.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
4.8 | 47.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
4.8 | 33.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
4.8 | 14.3 | GO:0005915 | zonula adherens(GO:0005915) |
4.7 | 42.7 | GO:0005869 | dynactin complex(GO:0005869) |
4.7 | 33.1 | GO:0005916 | fascia adherens(GO:0005916) |
4.7 | 9.4 | GO:0005914 | spot adherens junction(GO:0005914) |
4.7 | 18.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
4.7 | 18.8 | GO:0097470 | ribbon synapse(GO:0097470) |
4.7 | 14.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
4.7 | 14.0 | GO:1990462 | omegasome(GO:1990462) |
4.7 | 79.1 | GO:0045120 | pronucleus(GO:0045120) |
4.7 | 9.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
4.7 | 46.5 | GO:0002102 | podosome(GO:0002102) |
4.6 | 13.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
4.6 | 4.6 | GO:0033270 | paranode region of axon(GO:0033270) |
4.6 | 9.2 | GO:0005683 | U7 snRNP(GO:0005683) |
4.6 | 13.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
4.6 | 45.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
4.6 | 9.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
4.6 | 96.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
4.6 | 9.1 | GO:0032432 | actin filament bundle(GO:0032432) |
4.6 | 13.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
4.5 | 36.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
4.5 | 13.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
4.5 | 22.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
4.5 | 85.6 | GO:0016459 | myosin complex(GO:0016459) |
4.5 | 13.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
4.5 | 344.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
4.5 | 26.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
4.5 | 13.4 | GO:0005687 | U4 snRNP(GO:0005687) |
4.4 | 26.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
4.4 | 48.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
4.4 | 1091.2 | GO:0005925 | focal adhesion(GO:0005925) |
4.4 | 13.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
4.4 | 95.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
4.4 | 13.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
4.3 | 26.0 | GO:0042383 | sarcolemma(GO:0042383) |
4.3 | 21.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
4.3 | 81.4 | GO:0042588 | zymogen granule(GO:0042588) |
4.3 | 77.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
4.3 | 12.8 | GO:0005745 | m-AAA complex(GO:0005745) |
4.3 | 25.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
4.2 | 80.2 | GO:0090544 | BAF-type complex(GO:0090544) |
4.2 | 21.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
4.2 | 20.9 | GO:0005796 | Golgi lumen(GO:0005796) |
4.2 | 33.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
4.2 | 16.6 | GO:0045180 | basal cortex(GO:0045180) |
4.1 | 41.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
4.1 | 20.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
4.1 | 20.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
4.1 | 16.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
4.0 | 8.1 | GO:0033269 | internode region of axon(GO:0033269) |
4.0 | 4.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
4.0 | 24.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
4.0 | 20.1 | GO:0061617 | MICOS complex(GO:0061617) |
4.0 | 23.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
4.0 | 7.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
4.0 | 7.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
4.0 | 15.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
3.9 | 31.5 | GO:0042581 | specific granule(GO:0042581) |
3.9 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
3.9 | 11.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
3.8 | 138.4 | GO:0005776 | autophagosome(GO:0005776) |
3.8 | 11.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
3.8 | 23.0 | GO:0042627 | chylomicron(GO:0042627) |
3.8 | 56.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
3.8 | 83.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
3.8 | 60.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
3.7 | 3.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.7 | 29.5 | GO:0070652 | HAUS complex(GO:0070652) |
3.7 | 18.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
3.6 | 10.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
3.6 | 25.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
3.6 | 54.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
3.6 | 7.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
3.6 | 36.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.6 | 50.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
3.6 | 21.5 | GO:0099738 | cell cortex region(GO:0099738) |
3.5 | 10.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
3.5 | 21.0 | GO:0042587 | glycogen granule(GO:0042587) |
3.5 | 10.5 | GO:0097342 | ripoptosome(GO:0097342) |
3.5 | 34.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
3.5 | 17.4 | GO:0071439 | clathrin complex(GO:0071439) |
3.5 | 20.7 | GO:0031932 | TORC2 complex(GO:0031932) |
3.5 | 58.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
3.4 | 27.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
3.4 | 17.2 | GO:0070695 | FHF complex(GO:0070695) |
3.4 | 34.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
3.4 | 37.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
3.4 | 6.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
3.4 | 57.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
3.4 | 34.0 | GO:0031011 | Ino80 complex(GO:0031011) |
3.4 | 13.6 | GO:0030914 | STAGA complex(GO:0030914) |
3.4 | 27.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
3.4 | 10.1 | GO:0031417 | NatC complex(GO:0031417) |
3.4 | 23.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
3.4 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.4 | 154.5 | GO:0016363 | nuclear matrix(GO:0016363) |
3.3 | 153.7 | GO:0016605 | PML body(GO:0016605) |
3.3 | 23.3 | GO:0033263 | CORVET complex(GO:0033263) |
3.3 | 26.4 | GO:0034464 | BBSome(GO:0034464) |
3.3 | 9.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
3.3 | 62.2 | GO:0000786 | nucleosome(GO:0000786) |
3.3 | 19.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.3 | 81.5 | GO:0016592 | mediator complex(GO:0016592) |
3.3 | 9.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.3 | 29.3 | GO:0097546 | ciliary base(GO:0097546) |
3.2 | 22.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
3.2 | 3.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
3.2 | 35.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
3.2 | 9.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
3.2 | 3.2 | GO:0044327 | dendritic spine head(GO:0044327) |
3.2 | 9.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
3.2 | 9.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
3.2 | 38.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
3.2 | 34.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
3.2 | 12.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
3.1 | 28.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
3.1 | 6.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
3.1 | 12.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
3.1 | 9.3 | GO:0044194 | cytolytic granule(GO:0044194) |
3.1 | 24.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
3.1 | 37.1 | GO:0043196 | varicosity(GO:0043196) |
3.1 | 33.8 | GO:0032039 | integrator complex(GO:0032039) |
3.0 | 6.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
3.0 | 68.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
3.0 | 6.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
3.0 | 140.0 | GO:0005811 | lipid particle(GO:0005811) |
2.9 | 153.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
2.9 | 20.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.9 | 5.8 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
2.9 | 97.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
2.9 | 5.7 | GO:0043218 | compact myelin(GO:0043218) |
2.9 | 34.4 | GO:0000242 | pericentriolar material(GO:0000242) |
2.9 | 8.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.8 | 8.5 | GO:0010369 | chromocenter(GO:0010369) |
2.8 | 16.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.8 | 5.6 | GO:0016460 | myosin II complex(GO:0016460) |
2.8 | 326.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
2.8 | 11.2 | GO:0045298 | tubulin complex(GO:0045298) |
2.8 | 30.7 | GO:0036379 | myofilament(GO:0036379) |
2.8 | 2.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.8 | 30.3 | GO:0005657 | replication fork(GO:0005657) |
2.7 | 16.5 | GO:0032009 | early phagosome(GO:0032009) |
2.7 | 10.9 | GO:0005694 | chromosome(GO:0005694) |
2.7 | 8.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
2.7 | 34.8 | GO:0044453 | nuclear membrane part(GO:0044453) |
2.7 | 10.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.7 | 48.1 | GO:0015030 | Cajal body(GO:0015030) |
2.7 | 8.0 | GO:0030891 | VCB complex(GO:0030891) |
2.7 | 32.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.7 | 8.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
2.7 | 2.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.6 | 7.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.6 | 2.6 | GO:0034399 | nuclear periphery(GO:0034399) |
2.6 | 20.8 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
2.6 | 5.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
2.6 | 28.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
2.6 | 2.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.5 | 63.7 | GO:0012505 | endomembrane system(GO:0012505) |
2.5 | 38.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.5 | 60.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.5 | 17.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.5 | 12.6 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
2.5 | 72.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
2.5 | 32.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
2.5 | 22.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.4 | 68.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
2.4 | 14.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
2.4 | 7.3 | GO:0097255 | R2TP complex(GO:0097255) |
2.4 | 7.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.4 | 21.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
2.4 | 7.3 | GO:0097542 | ciliary tip(GO:0097542) |
2.4 | 4.8 | GO:0000796 | condensin complex(GO:0000796) |
2.4 | 2.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
2.4 | 21.7 | GO:0036452 | ESCRT complex(GO:0036452) |
2.4 | 26.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
2.4 | 38.0 | GO:0001772 | immunological synapse(GO:0001772) |
2.4 | 97.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
2.4 | 9.5 | GO:0001520 | outer dense fiber(GO:0001520) |
2.4 | 144.6 | GO:0001726 | ruffle(GO:0001726) |
2.4 | 97.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
2.3 | 16.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
2.3 | 16.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.3 | 46.9 | GO:0031901 | early endosome membrane(GO:0031901) |
2.3 | 262.0 | GO:0031965 | nuclear membrane(GO:0031965) |
2.3 | 9.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.3 | 455.5 | GO:0005667 | transcription factor complex(GO:0005667) |
2.3 | 2.3 | GO:0046930 | pore complex(GO:0046930) |
2.3 | 46.1 | GO:0032040 | small-subunit processome(GO:0032040) |
2.3 | 181.1 | GO:0072562 | blood microparticle(GO:0072562) |
2.3 | 4.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.3 | 22.7 | GO:0005771 | multivesicular body(GO:0005771) |
2.3 | 34.0 | GO:0000145 | exocyst(GO:0000145) |
2.3 | 11.3 | GO:0034709 | methylosome(GO:0034709) |
2.2 | 15.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
2.2 | 8.9 | GO:0031143 | pseudopodium(GO:0031143) |
2.2 | 8.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
2.2 | 2393.2 | GO:0005654 | nucleoplasm(GO:0005654) |
2.2 | 28.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.2 | 8.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.2 | 13.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.2 | 229.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
2.2 | 129.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
2.2 | 8.7 | GO:0071953 | elastic fiber(GO:0071953) |
2.2 | 17.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
2.2 | 2.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
2.2 | 6.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.2 | 10.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.2 | 25.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
2.2 | 2.2 | GO:0042827 | platelet dense granule(GO:0042827) |
2.1 | 2.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
2.1 | 19.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
2.1 | 27.4 | GO:0005876 | spindle microtubule(GO:0005876) |
2.1 | 16.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.1 | 104.4 | GO:0005903 | brush border(GO:0005903) |
2.1 | 8.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.1 | 6.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
2.1 | 6.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.1 | 18.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.1 | 8.2 | GO:0035861 | site of double-strand break(GO:0035861) |
2.0 | 8.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
2.0 | 53.2 | GO:0030496 | midbody(GO:0030496) |
2.0 | 12.2 | GO:0042599 | lamellar body(GO:0042599) |
2.0 | 16.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.0 | 2.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.0 | 6.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.0 | 16.0 | GO:0097225 | sperm midpiece(GO:0097225) |
2.0 | 53.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
2.0 | 4.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.0 | 2.0 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
2.0 | 2.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.0 | 5.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.0 | 7.8 | GO:0005874 | microtubule(GO:0005874) |
1.9 | 1.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.9 | 89.4 | GO:0005769 | early endosome(GO:0005769) |
1.9 | 3.9 | GO:0098536 | deuterosome(GO:0098536) |
1.9 | 1.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.9 | 3.7 | GO:0005871 | kinesin complex(GO:0005871) |
1.9 | 57.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.9 | 5.6 | GO:1990923 | PET complex(GO:1990923) |
1.8 | 47.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.8 | 7.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.8 | 18.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.8 | 23.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.8 | 59.1 | GO:0000776 | kinetochore(GO:0000776) |
1.8 | 3.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.8 | 55.3 | GO:0000922 | spindle pole(GO:0000922) |
1.8 | 5.3 | GO:0031512 | motile primary cilium(GO:0031512) |
1.8 | 5.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.7 | 8.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.7 | 3.4 | GO:0097422 | tubular endosome(GO:0097422) |
1.7 | 5.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.7 | 52.3 | GO:0005938 | cell cortex(GO:0005938) |
1.7 | 152.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.7 | 5.0 | GO:0071797 | LUBAC complex(GO:0071797) |
1.7 | 10.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.7 | 8.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.7 | 1282.9 | GO:0005829 | cytosol(GO:0005829) |
1.6 | 46.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.6 | 32.9 | GO:0000502 | proteasome complex(GO:0000502) |
1.6 | 3.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.6 | 6.5 | GO:0071546 | pi-body(GO:0071546) |
1.6 | 420.6 | GO:0005730 | nucleolus(GO:0005730) |
1.6 | 1.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.5 | 3.1 | GO:0005955 | calcineurin complex(GO:0005955) |
1.5 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.5 | 4.5 | GO:0000346 | transcription export complex(GO:0000346) |
1.5 | 14.9 | GO:0001527 | microfibril(GO:0001527) |
1.5 | 5.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.5 | 212.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.4 | 1.4 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.4 | 8.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.4 | 4.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.4 | 4.1 | GO:0031090 | organelle membrane(GO:0031090) |
1.4 | 9.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 5.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 1507.4 | GO:0070062 | extracellular exosome(GO:0070062) |
1.3 | 1.3 | GO:0014704 | intercalated disc(GO:0014704) |
1.3 | 8.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.2 | 8.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.2 | 4.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.2 | 2.4 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 3.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.2 | 4.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.2 | 146.1 | GO:0005813 | centrosome(GO:0005813) |
1.1 | 871.5 | GO:0005739 | mitochondrion(GO:0005739) |
1.1 | 4.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.1 | 15.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.1 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.0 | 32.2 | GO:0031514 | motile cilium(GO:0031514) |
1.0 | 17.6 | GO:0005922 | connexon complex(GO:0005922) |
1.0 | 8.3 | GO:0036157 | outer dynein arm(GO:0036157) |
1.0 | 21.2 | GO:0000793 | condensed chromosome(GO:0000793) |
1.0 | 1.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.9 | 0.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.9 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.9 | 16.8 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 38.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.9 | 38.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.8 | 30.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.8 | 1448.0 | GO:0005634 | nucleus(GO:0005634) |
0.7 | 5.8 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.7 | 0.7 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 1.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.7 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.6 | 10.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.6 | 10.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 0.6 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.6 | 55.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.6 | 1.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 15.7 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.6 | 3.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 29.2 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.5 | 2.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 60.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 1.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 2.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 11.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.3 | 13.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 15.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 4.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 11.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 5.8 | GO:0099513 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.3 | 505.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.3 | 69.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
20.5 | 61.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
18.4 | 55.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
18.1 | 108.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
18.1 | 18.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
17.0 | 84.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
15.5 | 108.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
15.4 | 15.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
14.5 | 57.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
14.2 | 42.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
14.1 | 56.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
13.8 | 55.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
13.7 | 41.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
13.2 | 39.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
13.1 | 91.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
12.7 | 12.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
12.7 | 38.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
12.2 | 36.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
12.2 | 24.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
12.1 | 12.1 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
12.0 | 48.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
12.0 | 12.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
12.0 | 143.5 | GO:0017166 | vinculin binding(GO:0017166) |
11.9 | 35.6 | GO:0050692 | DBD domain binding(GO:0050692) |
11.8 | 35.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
11.8 | 35.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
11.7 | 93.6 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
11.7 | 104.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
11.6 | 34.9 | GO:0035877 | death effector domain binding(GO:0035877) |
11.5 | 34.6 | GO:0031014 | troponin T binding(GO:0031014) |
10.9 | 32.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
10.9 | 32.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
10.9 | 86.8 | GO:0008430 | selenium binding(GO:0008430) |
10.8 | 75.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
10.8 | 32.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
10.7 | 42.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
10.4 | 52.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
10.4 | 31.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
10.4 | 31.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
10.3 | 41.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
10.2 | 10.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
10.1 | 30.3 | GO:0030172 | troponin C binding(GO:0030172) |
10.0 | 59.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
10.0 | 99.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
9.9 | 19.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
9.9 | 39.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
9.9 | 39.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
9.9 | 49.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
9.7 | 19.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
9.6 | 76.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
9.6 | 28.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
9.5 | 28.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
9.4 | 18.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
9.3 | 27.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
9.3 | 55.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
9.0 | 45.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
8.9 | 26.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
8.9 | 35.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
8.9 | 26.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
8.8 | 26.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
8.7 | 17.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
8.7 | 26.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
8.6 | 51.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
8.6 | 102.7 | GO:0044548 | S100 protein binding(GO:0044548) |
8.5 | 42.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
8.4 | 33.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
8.3 | 50.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
8.1 | 24.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
8.0 | 24.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
8.0 | 31.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
8.0 | 31.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
7.9 | 55.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
7.9 | 23.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
7.8 | 39.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
7.8 | 7.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
7.7 | 46.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
7.7 | 30.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
7.7 | 153.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
7.7 | 23.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
7.7 | 107.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
7.6 | 30.6 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
7.5 | 15.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
7.5 | 60.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
7.5 | 74.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
7.5 | 22.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
7.5 | 59.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
7.4 | 37.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
7.3 | 36.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.3 | 43.8 | GO:0008199 | ferric iron binding(GO:0008199) |
7.3 | 50.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
7.2 | 28.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
7.2 | 7.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
7.2 | 14.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
7.2 | 7.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
7.1 | 14.3 | GO:0030911 | TPR domain binding(GO:0030911) |
7.1 | 64.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
7.1 | 21.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
7.1 | 21.3 | GO:0019961 | interferon binding(GO:0019961) |
7.1 | 141.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
7.1 | 21.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
7.0 | 27.9 | GO:0043515 | kinetochore binding(GO:0043515) |
6.9 | 97.2 | GO:0008143 | poly(A) binding(GO:0008143) |
6.9 | 55.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
6.9 | 20.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
6.9 | 20.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
6.8 | 27.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
6.7 | 33.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
6.7 | 74.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
6.7 | 26.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
6.7 | 40.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
6.7 | 86.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
6.7 | 20.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
6.6 | 26.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
6.6 | 19.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
6.6 | 26.2 | GO:0009374 | biotin binding(GO:0009374) |
6.5 | 6.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
6.5 | 26.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
6.5 | 26.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
6.5 | 19.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
6.5 | 129.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
6.5 | 19.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
6.5 | 135.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
6.4 | 19.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
6.4 | 6.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.3 | 19.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
6.3 | 25.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
6.3 | 189.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
6.3 | 18.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
6.3 | 6.3 | GO:0050693 | LBD domain binding(GO:0050693) |
6.3 | 50.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
6.3 | 25.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
6.2 | 24.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
6.2 | 18.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
6.1 | 24.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
6.1 | 12.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
6.1 | 48.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
6.0 | 42.2 | GO:0018634 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
6.0 | 24.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
6.0 | 6.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
5.9 | 23.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
5.9 | 53.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
5.9 | 52.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
5.8 | 17.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
5.8 | 28.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
5.7 | 34.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
5.7 | 40.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
5.7 | 34.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
5.7 | 22.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
5.7 | 5.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
5.7 | 90.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
5.6 | 16.8 | GO:0001032 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
5.6 | 39.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
5.5 | 16.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
5.5 | 22.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
5.5 | 71.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
5.5 | 27.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
5.4 | 21.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
5.4 | 21.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
5.4 | 65.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
5.4 | 48.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
5.4 | 16.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
5.4 | 43.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
5.4 | 21.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
5.4 | 10.7 | GO:0015928 | fucosidase activity(GO:0015928) |
5.4 | 75.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
5.4 | 32.1 | GO:0050700 | CARD domain binding(GO:0050700) |
5.3 | 48.1 | GO:0031996 | thioesterase binding(GO:0031996) |
5.3 | 5.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
5.3 | 26.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
5.3 | 15.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
5.3 | 42.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
5.2 | 42.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
5.2 | 26.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
5.2 | 15.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
5.2 | 20.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
5.2 | 25.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
5.1 | 10.3 | GO:0030519 | snoRNP binding(GO:0030519) |
5.1 | 51.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
5.1 | 35.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
5.1 | 45.7 | GO:0005123 | death receptor binding(GO:0005123) |
5.1 | 10.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
5.1 | 35.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
5.1 | 65.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
5.1 | 10.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
5.1 | 30.4 | GO:0051400 | BH domain binding(GO:0051400) |
5.1 | 5.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
5.0 | 95.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
5.0 | 25.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
5.0 | 10.1 | GO:1990188 | euchromatin binding(GO:1990188) |
5.0 | 10.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
5.0 | 15.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
5.0 | 10.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
5.0 | 14.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
5.0 | 89.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
4.9 | 9.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
4.9 | 14.8 | GO:0042731 | PH domain binding(GO:0042731) |
4.9 | 14.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
4.9 | 34.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
4.9 | 9.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
4.9 | 48.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
4.9 | 150.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
4.9 | 53.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
4.8 | 38.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
4.8 | 57.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
4.8 | 4.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
4.8 | 19.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
4.8 | 52.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
4.8 | 23.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
4.8 | 14.4 | GO:0000339 | RNA cap binding(GO:0000339) |
4.8 | 9.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
4.8 | 28.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
4.8 | 33.3 | GO:0031432 | titin binding(GO:0031432) |
4.7 | 47.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
4.7 | 18.9 | GO:0030274 | LIM domain binding(GO:0030274) |
4.7 | 37.7 | GO:1990405 | protein antigen binding(GO:1990405) |
4.7 | 28.2 | GO:0015288 | porin activity(GO:0015288) |
4.7 | 9.4 | GO:0045340 | mercury ion binding(GO:0045340) |
4.7 | 32.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.7 | 14.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
4.7 | 18.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
4.6 | 13.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
4.6 | 13.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
4.6 | 23.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
4.6 | 13.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
4.6 | 9.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
4.6 | 4.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
4.6 | 110.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
4.6 | 41.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
4.6 | 55.1 | GO:0005521 | lamin binding(GO:0005521) |
4.6 | 9.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
4.6 | 9.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
4.6 | 197.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
4.6 | 13.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
4.6 | 18.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
4.6 | 22.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
4.6 | 18.2 | GO:0005534 | galactose binding(GO:0005534) |
4.5 | 40.9 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
4.5 | 9.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
4.5 | 22.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
4.5 | 18.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
4.5 | 4.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
4.5 | 17.9 | GO:0038132 | neuregulin binding(GO:0038132) |
4.5 | 22.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
4.5 | 4.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
4.4 | 4.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
4.4 | 4.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
4.4 | 150.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
4.4 | 4.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
4.4 | 52.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
4.4 | 8.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
4.4 | 13.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
4.4 | 8.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
4.4 | 39.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
4.4 | 121.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
4.3 | 17.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
4.3 | 4.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
4.3 | 21.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
4.3 | 68.9 | GO:0005112 | Notch binding(GO:0005112) |
4.3 | 29.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
4.3 | 17.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
4.3 | 21.3 | GO:0070728 | leucine binding(GO:0070728) |
4.3 | 42.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
4.2 | 8.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
4.2 | 8.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
4.2 | 29.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
4.2 | 21.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
4.2 | 8.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
4.2 | 16.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
4.2 | 33.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
4.2 | 33.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
4.2 | 4.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
4.2 | 12.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
4.2 | 29.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
4.2 | 8.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
4.2 | 12.5 | GO:0019767 | IgE receptor activity(GO:0019767) |
4.2 | 20.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
4.1 | 29.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
4.1 | 4.1 | GO:0010181 | FMN binding(GO:0010181) |
4.1 | 41.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
4.1 | 4.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
4.1 | 12.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
4.1 | 24.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
4.1 | 12.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
4.1 | 20.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
4.1 | 12.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
4.0 | 20.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.0 | 8.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
4.0 | 4.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
4.0 | 4.0 | GO:0019825 | oxygen binding(GO:0019825) |
4.0 | 20.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.0 | 52.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
4.0 | 99.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
4.0 | 4.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
4.0 | 8.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
4.0 | 55.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
4.0 | 15.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
4.0 | 7.9 | GO:0038100 | nodal binding(GO:0038100) |
4.0 | 15.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
4.0 | 7.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.9 | 98.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
3.9 | 19.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
3.9 | 11.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
3.9 | 11.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.9 | 27.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
3.9 | 42.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
3.9 | 38.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
3.9 | 54.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
3.8 | 15.4 | GO:0015232 | heme transporter activity(GO:0015232) |
3.8 | 3.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
3.8 | 15.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
3.8 | 7.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
3.8 | 145.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.8 | 15.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.8 | 19.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
3.8 | 19.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
3.8 | 7.6 | GO:0043559 | insulin binding(GO:0043559) |
3.8 | 7.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.8 | 162.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
3.8 | 11.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
3.8 | 26.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
3.7 | 67.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
3.7 | 7.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
3.7 | 33.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
3.7 | 37.3 | GO:0004568 | chitinase activity(GO:0004568) |
3.7 | 63.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
3.7 | 18.6 | GO:0017040 | ceramidase activity(GO:0017040) |
3.7 | 33.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
3.7 | 7.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
3.7 | 11.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
3.7 | 18.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
3.7 | 14.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
3.7 | 7.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
3.6 | 14.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
3.6 | 10.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
3.6 | 14.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
3.6 | 10.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
3.6 | 18.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.6 | 7.2 | GO:0034618 | arginine binding(GO:0034618) |
3.6 | 10.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
3.6 | 10.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
3.6 | 17.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
3.6 | 39.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
3.6 | 10.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
3.6 | 35.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
3.6 | 10.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.6 | 17.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
3.6 | 21.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
3.6 | 17.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.6 | 39.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
3.6 | 10.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.6 | 10.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.6 | 21.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
3.6 | 21.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
3.5 | 14.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
3.5 | 14.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.5 | 14.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
3.5 | 14.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.5 | 21.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.5 | 7.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
3.5 | 10.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.5 | 87.3 | GO:0043236 | laminin binding(GO:0043236) |
3.5 | 34.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
3.5 | 163.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
3.5 | 6.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
3.5 | 55.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
3.5 | 13.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.4 | 6.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
3.4 | 10.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
3.4 | 6.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
3.4 | 23.9 | GO:0016208 | AMP binding(GO:0016208) |
3.4 | 40.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
3.4 | 33.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.4 | 16.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
3.4 | 23.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
3.4 | 20.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
3.4 | 27.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
3.4 | 10.1 | GO:0055100 | adiponectin binding(GO:0055100) |
3.4 | 33.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.4 | 10.1 | GO:0000182 | rDNA binding(GO:0000182) |
3.4 | 13.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
3.4 | 6.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
3.4 | 20.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.3 | 13.4 | GO:0070513 | death domain binding(GO:0070513) |
3.3 | 3.3 | GO:0035197 | siRNA binding(GO:0035197) |
3.3 | 6.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.3 | 23.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
3.3 | 30.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
3.3 | 10.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.3 | 20.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
3.3 | 13.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
3.3 | 212.0 | GO:0005178 | integrin binding(GO:0005178) |
3.3 | 16.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
3.3 | 39.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
3.3 | 42.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
3.3 | 26.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
3.3 | 29.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
3.3 | 6.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
3.3 | 13.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
3.2 | 32.5 | GO:0052773 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
3.2 | 42.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
3.2 | 32.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
3.2 | 6.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.2 | 9.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
3.2 | 16.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
3.2 | 6.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
3.2 | 9.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.2 | 9.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.2 | 38.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
3.2 | 16.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
3.2 | 19.1 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
3.2 | 44.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
3.2 | 6.4 | GO:0015923 | mannosidase activity(GO:0015923) |
3.2 | 31.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
3.2 | 19.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.1 | 9.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
3.1 | 159.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
3.1 | 12.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
3.1 | 3.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
3.1 | 3.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
3.1 | 6.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
3.1 | 77.7 | GO:0015485 | cholesterol binding(GO:0015485) |
3.1 | 3.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
3.1 | 49.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.1 | 3.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
3.1 | 27.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
3.1 | 157.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
3.1 | 12.3 | GO:0030984 | kininogen binding(GO:0030984) |
3.1 | 15.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.1 | 9.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
3.1 | 6.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
3.1 | 186.2 | GO:0001047 | core promoter binding(GO:0001047) |
3.0 | 12.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
3.0 | 24.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
3.0 | 6.1 | GO:0004103 | choline kinase activity(GO:0004103) |
3.0 | 9.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
3.0 | 9.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.0 | 21.2 | GO:0046790 | virion binding(GO:0046790) |
3.0 | 9.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
3.0 | 24.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
3.0 | 45.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
3.0 | 12.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
3.0 | 15.1 | GO:0070694 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
3.0 | 12.0 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
3.0 | 59.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
3.0 | 3.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.0 | 273.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
3.0 | 3.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.0 | 14.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.0 | 11.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
3.0 | 5.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
2.9 | 5.9 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
2.9 | 8.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.9 | 2.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
2.9 | 26.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.9 | 29.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
2.9 | 2.9 | GO:0016530 | metallochaperone activity(GO:0016530) |
2.9 | 2.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.9 | 43.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
2.9 | 34.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.9 | 5.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.9 | 5.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.9 | 5.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.9 | 8.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.9 | 14.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.9 | 2.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.9 | 17.2 | GO:0050733 | RS domain binding(GO:0050733) |
2.9 | 25.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.8 | 39.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
2.8 | 8.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.8 | 33.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
2.8 | 8.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
2.8 | 8.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.8 | 2.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.8 | 19.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.8 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
2.8 | 92.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.8 | 8.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.8 | 13.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.8 | 2.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.8 | 8.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.8 | 80.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
2.8 | 24.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.8 | 16.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.8 | 5.5 | GO:0015925 | galactosidase activity(GO:0015925) |
2.8 | 2.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
2.7 | 2.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
2.7 | 62.9 | GO:0050699 | WW domain binding(GO:0050699) |
2.7 | 2.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
2.7 | 10.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
2.7 | 29.9 | GO:0043531 | ADP binding(GO:0043531) |
2.7 | 2.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
2.7 | 16.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.7 | 260.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
2.7 | 8.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.7 | 13.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
2.7 | 5.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
2.7 | 45.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
2.7 | 82.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
2.7 | 77.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
2.7 | 2.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.7 | 395.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
2.7 | 18.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
2.6 | 47.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
2.6 | 7.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.6 | 15.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.6 | 70.7 | GO:0005507 | copper ion binding(GO:0005507) |
2.6 | 2.6 | GO:0035671 | enone reductase activity(GO:0035671) |
2.6 | 73.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
2.6 | 39.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.6 | 49.6 | GO:0030515 | snoRNA binding(GO:0030515) |
2.6 | 7.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.6 | 7.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.6 | 23.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.6 | 23.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
2.6 | 44.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
2.6 | 7.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.6 | 10.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.6 | 7.7 | GO:0019808 | polyamine binding(GO:0019808) |
2.6 | 15.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.6 | 10.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.6 | 38.4 | GO:0045502 | dynein binding(GO:0045502) |
2.5 | 2.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.5 | 53.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
2.5 | 111.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
2.5 | 121.4 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
2.5 | 10.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.5 | 7.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.5 | 20.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.5 | 7.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.5 | 20.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
2.5 | 10.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
2.5 | 69.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.5 | 29.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
2.5 | 108.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
2.5 | 14.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
2.4 | 361.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
2.4 | 4.9 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
2.4 | 7.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.4 | 24.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
2.4 | 4.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
2.4 | 7.3 | GO:0019213 | deacetylase activity(GO:0019213) |
2.4 | 21.8 | GO:0030955 | potassium ion binding(GO:0030955) |
2.4 | 7.3 | GO:0004064 | arylesterase activity(GO:0004064) |
2.4 | 7.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.4 | 9.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
2.4 | 4.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.4 | 7.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.4 | 14.4 | GO:0045296 | cadherin binding(GO:0045296) |
2.4 | 40.9 | GO:0008483 | transaminase activity(GO:0008483) |
2.4 | 7.2 | GO:0043199 | sulfate binding(GO:0043199) |
2.4 | 59.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
2.4 | 119.1 | GO:0051020 | GTPase binding(GO:0051020) |
2.4 | 9.5 | GO:0035473 | lipase binding(GO:0035473) |
2.4 | 168.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
2.4 | 11.9 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
2.4 | 7.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.4 | 90.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
2.4 | 4.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.4 | 7.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.4 | 7.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.4 | 2.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.3 | 21.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.3 | 4.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
2.3 | 9.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
2.3 | 100.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
2.3 | 4.7 | GO:0008142 | oxysterol binding(GO:0008142) |
2.3 | 7.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.3 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.3 | 30.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.3 | 18.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
2.3 | 20.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.3 | 7.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
2.3 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
2.3 | 11.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
2.3 | 16.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.3 | 4.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.3 | 9.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.3 | 50.4 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
2.3 | 2.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.3 | 4.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
2.3 | 9.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.3 | 4.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.3 | 24.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.3 | 9.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
2.3 | 4.5 | GO:2001070 | starch binding(GO:2001070) |
2.3 | 15.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.3 | 29.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
2.3 | 27.0 | GO:0001618 | virus receptor activity(GO:0001618) |
2.2 | 63.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
2.2 | 13.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.2 | 73.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
2.2 | 13.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.2 | 48.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.2 | 6.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.2 | 19.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.2 | 436.6 | GO:0008134 | transcription factor binding(GO:0008134) |
2.2 | 6.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.2 | 4.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.2 | 13.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
2.2 | 43.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
2.2 | 141.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
2.2 | 2.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
2.2 | 4.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.2 | 60.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
2.2 | 12.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
2.1 | 10.7 | GO:0043274 | phospholipase binding(GO:0043274) |
2.1 | 25.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
2.1 | 2.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.1 | 6.3 | GO:0004359 | glutaminase activity(GO:0004359) |
2.1 | 25.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.1 | 8.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.1 | 6.2 | GO:0048038 | quinone binding(GO:0048038) |
2.1 | 4.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.1 | 18.6 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
2.1 | 8.3 | GO:0015266 | protein channel activity(GO:0015266) |
2.1 | 14.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.0 | 8.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.0 | 2.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.0 | 392.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
2.0 | 4.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
2.0 | 53.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
2.0 | 19.9 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
2.0 | 29.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
2.0 | 7.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.0 | 13.8 | GO:0039706 | co-receptor binding(GO:0039706) |
2.0 | 7.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
2.0 | 17.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
2.0 | 57.0 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
2.0 | 5.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.9 | 11.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.9 | 11.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.9 | 1.9 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.9 | 52.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
1.9 | 40.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
1.9 | 23.0 | GO:0016918 | retinal binding(GO:0016918) |
1.9 | 13.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.9 | 9.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.9 | 9.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.9 | 49.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.9 | 7.6 | GO:0005113 | patched binding(GO:0005113) |
1.9 | 58.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.9 | 7.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.9 | 3.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.9 | 13.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.9 | 5.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.9 | 3.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.9 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.8 | 1.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.8 | 14.7 | GO:0032451 | demethylase activity(GO:0032451) |
1.8 | 40.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.8 | 18.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.8 | 7.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.8 | 14.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.8 | 3.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.8 | 19.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.8 | 3.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.8 | 7.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.8 | 3.6 | GO:0031433 | telethonin binding(GO:0031433) |
1.8 | 12.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.8 | 17.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.8 | 12.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.7 | 7.0 | GO:0071253 | connexin binding(GO:0071253) |
1.7 | 1.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.7 | 96.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.7 | 5.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.7 | 13.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.7 | 1.7 | GO:0015927 | trehalase activity(GO:0015927) |
1.7 | 189.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
1.7 | 15.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.7 | 5.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.7 | 69.5 | GO:0002020 | protease binding(GO:0002020) |
1.7 | 84.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.6 | 41.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.6 | 4.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
1.6 | 3.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
1.6 | 4.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.6 | 4.9 | GO:0001846 | opsonin binding(GO:0001846) |
1.6 | 9.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.6 | 1.6 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
1.6 | 3.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.6 | 4.8 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.6 | 15.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.6 | 4.7 | GO:0005536 | glucose binding(GO:0005536) |
1.6 | 28.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.6 | 4.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.6 | 10.9 | GO:0043955 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.5 | 26.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.5 | 1.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.5 | 15.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.5 | 10.7 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
1.5 | 42.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.5 | 6.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.5 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.5 | 19.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.5 | 340.2 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
1.5 | 4.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
1.5 | 4.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.5 | 14.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.5 | 8.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.5 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 115.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
1.5 | 33.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
1.5 | 23.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.5 | 835.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.5 | 5.8 | GO:0004519 | endonuclease activity(GO:0004519) |
1.4 | 7.2 | GO:0042805 | actinin binding(GO:0042805) |
1.4 | 5.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.4 | 5.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.4 | 4.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.4 | 2.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.4 | 2.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.4 | 15.2 | GO:0043022 | ribosome binding(GO:0043022) |
1.4 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
1.4 | 4.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.4 | 91.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.4 | 10.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.3 | 2.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.3 | 5.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.3 | 2.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.3 | 157.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
1.3 | 4.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.3 | 1.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
1.3 | 2.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.3 | 23.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.3 | 56.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
1.3 | 1.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.3 | 28.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.3 | 9.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
1.3 | 1.3 | GO:0051373 | FATZ binding(GO:0051373) |
1.3 | 3.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.3 | 1.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.3 | 5.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
1.3 | 1.3 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.3 | 11.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.3 | 6.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.3 | 5.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.2 | 2.5 | GO:0019862 | IgA binding(GO:0019862) |
1.2 | 8.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
1.2 | 1.2 | GO:0070061 | fructose binding(GO:0070061) |
1.2 | 7.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.2 | 4.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.2 | 3.6 | GO:0002046 | opsin binding(GO:0002046) |
1.2 | 36.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.2 | 9.6 | GO:0016248 | channel inhibitor activity(GO:0016248) |
1.2 | 5.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.2 | 3.5 | GO:0031419 | cobalamin binding(GO:0031419) |
1.2 | 8.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.2 | 108.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.2 | 10.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.2 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.2 | 12.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.2 | 1.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.2 | 110.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.1 | 24.1 | GO:0005518 | collagen binding(GO:0005518) |
1.1 | 4.5 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
1.1 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.1 | 6.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.1 | 21.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.1 | 12.4 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
1.1 | 6.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.1 | 3.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.1 | 3.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.1 | 10.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.1 | 2.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.1 | 5.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.1 | 18.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.1 | 8.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
1.1 | 1.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.1 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.1 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
1.1 | 3.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.1 | 6.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.1 | 3.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
1.1 | 13.9 | GO:0015926 | glucosidase activity(GO:0015926) |
1.1 | 19.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.1 | 26.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
1.1 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.0 | 3.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.0 | 10.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.0 | 41.4 | GO:0008565 | protein transporter activity(GO:0008565) |
1.0 | 30.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
1.0 | 3.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.0 | 171.6 | GO:0003779 | actin binding(GO:0003779) |
1.0 | 2.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 1.0 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
1.0 | 3.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.0 | 4.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.0 | 7.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.0 | 11.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.9 | 0.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.9 | 6.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.9 | 2.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.9 | 1.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 2.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.9 | 0.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 51.5 | GO:0003774 | motor activity(GO:0003774) |
0.9 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.8 | 38.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 20.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.8 | 274.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.8 | 5.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 7.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 2.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 10.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.8 | 1.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.8 | 37.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.8 | 3.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.8 | 4.6 | GO:0016853 | isomerase activity(GO:0016853) |
0.8 | 15.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.7 | 3.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 3.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.7 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 1.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 1.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.7 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.7 | 12.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.7 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 3.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.7 | 2.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 5.0 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.6 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 1.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.6 | 11.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.6 | 1.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.6 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 0.6 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.6 | 2.8 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 3.4 | GO:0042287 | MHC protein binding(GO:0042287) |
0.6 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 11.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 0.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.5 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 5.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 0.5 | GO:0032934 | sterol binding(GO:0032934) |
0.5 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 6.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.5 | 73.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 3.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 1.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 0.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 1.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 0.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.5 | 12.2 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.4 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 1.6 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.4 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 4.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 63.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.4 | 1.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 13.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 1.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 9.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.3 | 2.3 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 3.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 9.2 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 17.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 21.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 3.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 126.2 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 4.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 21.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 1.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 11.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 99.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.3 | 11.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
10.2 | 215.1 | PID IGF1 PATHWAY | IGF1 pathway |
10.2 | 122.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
10.1 | 91.3 | ST STAT3 PATHWAY | STAT3 Pathway |
9.8 | 234.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
9.5 | 255.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
9.3 | 18.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
8.8 | 123.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
8.3 | 58.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
8.0 | 79.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
7.9 | 118.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
7.9 | 110.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
7.9 | 118.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
7.8 | 109.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
7.6 | 342.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
7.4 | 185.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
6.9 | 130.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
6.8 | 94.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
6.8 | 162.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
6.7 | 161.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
6.6 | 263.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
6.6 | 217.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
6.5 | 130.6 | PID AURORA A PATHWAY | Aurora A signaling |
6.2 | 43.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
6.0 | 24.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
6.0 | 226.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
6.0 | 59.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
5.9 | 23.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
5.9 | 70.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
5.9 | 41.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
5.7 | 182.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
5.6 | 5.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
5.6 | 244.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
5.5 | 27.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
5.5 | 131.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
5.4 | 211.3 | PID P53 REGULATION PATHWAY | p53 pathway |
5.4 | 32.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
5.4 | 107.4 | PID RHOA PATHWAY | RhoA signaling pathway |
5.2 | 104.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
5.1 | 244.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
5.1 | 60.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
5.0 | 85.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
5.0 | 10.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
5.0 | 59.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
4.9 | 24.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.9 | 4.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
4.8 | 125.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
4.8 | 57.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
4.8 | 9.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
4.8 | 158.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
4.8 | 61.8 | PID MYC PATHWAY | C-MYC pathway |
4.5 | 4.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
4.5 | 18.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
4.5 | 31.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
4.4 | 53.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
4.4 | 39.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
4.3 | 78.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
4.3 | 34.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
4.3 | 21.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
4.3 | 4.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
4.2 | 114.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
4.2 | 139.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.2 | 125.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
4.2 | 104.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
4.1 | 48.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
4.0 | 4.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.7 | 107.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
3.7 | 11.1 | PID ALK2 PATHWAY | ALK2 signaling events |
3.7 | 58.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
3.7 | 33.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
3.6 | 57.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
3.5 | 81.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
3.5 | 21.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
3.5 | 48.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
3.4 | 60.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
3.3 | 67.0 | PID PLK1 PATHWAY | PLK1 signaling events |
3.3 | 49.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
3.3 | 42.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
3.2 | 42.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
3.2 | 90.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
3.1 | 22.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
3.1 | 119.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
3.1 | 34.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
3.1 | 9.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
3.1 | 190.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
3.0 | 18.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
3.0 | 54.3 | PID ATR PATHWAY | ATR signaling pathway |
3.0 | 3.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
3.0 | 75.0 | PID P73PATHWAY | p73 transcription factor network |
2.9 | 14.4 | PID ATM PATHWAY | ATM pathway |
2.9 | 31.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
2.9 | 40.0 | PID ARF 3PATHWAY | Arf1 pathway |
2.9 | 20.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.8 | 5.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.7 | 65.5 | PID AURORA B PATHWAY | Aurora B signaling |
2.7 | 21.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.7 | 16.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
2.7 | 90.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.6 | 55.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
2.6 | 15.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
2.6 | 26.0 | PID BCR 5PATHWAY | BCR signaling pathway |
2.6 | 44.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
2.6 | 28.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.6 | 7.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.5 | 40.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.5 | 7.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.5 | 32.0 | PID RAS PATHWAY | Regulation of Ras family activation |
2.4 | 39.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.4 | 17.0 | ST GAQ PATHWAY | G alpha q Pathway |
2.4 | 21.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.4 | 16.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
2.3 | 16.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
2.3 | 18.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
2.2 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
2.2 | 28.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.0 | 6.1 | PID IFNG PATHWAY | IFN-gamma pathway |
2.0 | 28.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
2.0 | 4.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.9 | 36.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.9 | 7.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.8 | 18.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.8 | 21.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.7 | 1.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.7 | 15.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.7 | 31.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.7 | 5.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.7 | 8.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.7 | 46.6 | PID NOTCH PATHWAY | Notch signaling pathway |
1.6 | 18.1 | PID BARD1 PATHWAY | BARD1 signaling events |
1.6 | 6.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.6 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 20.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.5 | 42.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.5 | 191.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.5 | 7.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.4 | 8.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.4 | 7.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.4 | 14.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.3 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.3 | 2.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.3 | 3.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.2 | 3.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.1 | 5.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 210.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.1 | 13.1 | PID ALK1 PATHWAY | ALK1 signaling events |
1.1 | 3.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.1 | 2.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 11.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.0 | 18.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 10.3 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 12.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.0 | 11.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.9 | 1.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.9 | 7.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.9 | 1.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.9 | 5.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.9 | 7.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.9 | 11.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 6.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 5.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.7 | 29.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 7.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 8.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 3.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 2.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 62.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 3.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 3.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 3.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.4 | 15.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
13.0 | 234.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
13.0 | 13.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
10.4 | 166.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
10.1 | 50.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
9.9 | 237.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
9.8 | 9.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
9.0 | 170.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
8.6 | 77.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
8.5 | 119.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
8.4 | 67.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
8.3 | 91.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
8.0 | 31.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
7.9 | 151.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
7.9 | 79.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
7.7 | 38.7 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
7.5 | 74.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
7.5 | 104.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
7.4 | 59.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
7.4 | 51.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
7.4 | 66.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
7.2 | 43.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
7.2 | 194.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
7.2 | 165.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
7.1 | 113.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
7.1 | 91.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
6.8 | 41.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
6.8 | 75.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
6.6 | 157.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
6.5 | 104.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
6.5 | 65.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
6.5 | 58.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
6.4 | 70.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
6.3 | 37.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
6.2 | 68.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
6.2 | 55.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
6.0 | 6.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
6.0 | 53.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
5.9 | 35.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
5.9 | 59.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
5.9 | 87.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
5.8 | 81.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
5.8 | 46.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
5.6 | 129.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
5.6 | 128.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
5.6 | 33.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
5.6 | 33.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
5.6 | 508.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
5.5 | 104.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
5.4 | 32.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.4 | 204.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
5.2 | 157.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
5.2 | 120.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
5.2 | 36.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
5.1 | 20.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
5.0 | 5.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
4.9 | 4.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
4.8 | 48.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
4.8 | 130.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
4.8 | 47.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
4.7 | 4.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
4.7 | 75.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
4.7 | 97.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
4.6 | 60.3 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
4.6 | 9.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
4.6 | 46.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
4.6 | 82.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
4.6 | 13.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
4.6 | 41.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
4.5 | 44.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
4.5 | 26.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
4.5 | 76.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
4.5 | 286.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
4.4 | 13.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
4.4 | 22.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
4.3 | 108.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
4.2 | 46.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
4.1 | 41.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
4.1 | 28.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
4.1 | 143.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
4.1 | 16.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
4.1 | 40.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
4.0 | 4.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
4.0 | 63.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
4.0 | 7.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.9 | 27.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
3.9 | 11.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
3.9 | 120.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
3.9 | 57.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.9 | 73.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
3.8 | 61.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
3.8 | 26.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
3.8 | 41.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
3.8 | 95.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
3.8 | 353.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
3.8 | 113.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
3.8 | 11.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
3.8 | 15.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.8 | 234.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
3.7 | 37.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.7 | 168.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
3.7 | 310.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.7 | 29.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.6 | 107.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
3.6 | 50.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
3.5 | 10.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
3.4 | 72.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
3.4 | 24.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
3.4 | 10.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.4 | 27.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
3.4 | 124.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
3.2 | 29.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
3.2 | 13.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
3.2 | 35.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
3.2 | 32.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.2 | 99.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
3.2 | 38.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.2 | 63.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
3.1 | 3.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
3.1 | 15.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
3.1 | 12.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
3.1 | 12.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
3.0 | 30.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
3.0 | 3.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
3.0 | 24.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
3.0 | 38.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.9 | 35.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.9 | 17.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.9 | 5.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.8 | 119.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
2.8 | 98.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.8 | 5.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
2.7 | 16.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.7 | 92.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
2.7 | 16.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.7 | 59.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.6 | 10.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
2.6 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
2.6 | 18.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
2.6 | 10.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
2.6 | 28.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.6 | 23.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
2.6 | 41.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
2.5 | 15.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
2.5 | 12.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.5 | 2.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.4 | 51.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.4 | 21.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
2.4 | 28.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.4 | 14.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.4 | 202.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.4 | 11.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.4 | 9.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.3 | 18.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.3 | 34.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
2.3 | 46.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
2.3 | 39.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
2.3 | 22.7 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
2.2 | 4.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.2 | 24.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
2.2 | 22.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.2 | 29.1 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
2.2 | 95.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
2.2 | 8.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.1 | 51.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
2.1 | 10.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.1 | 40.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.1 | 16.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.1 | 8.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.1 | 35.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.0 | 14.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
2.0 | 54.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.0 | 12.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.0 | 74.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.9 | 5.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.9 | 23.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.9 | 28.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.9 | 24.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.8 | 16.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.8 | 14.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.8 | 267.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.8 | 3.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
1.8 | 5.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.7 | 10.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.7 | 22.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.7 | 18.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.7 | 17.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.7 | 10.2 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
1.6 | 47.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
1.6 | 21.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.6 | 27.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.6 | 19.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
1.6 | 23.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.6 | 11.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.5 | 13.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.5 | 41.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.5 | 10.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.5 | 5.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.5 | 21.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.5 | 4.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.4 | 4.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.4 | 49.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.4 | 9.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.4 | 6.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.4 | 34.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.3 | 5.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.3 | 7.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.3 | 15.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
1.3 | 7.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.3 | 15.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.3 | 15.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
1.3 | 15.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.3 | 7.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.3 | 17.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
1.2 | 34.9 | REACTOME TRANSLATION | Genes involved in Translation |
1.2 | 14.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.2 | 11.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.2 | 10.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 47.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 10.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.1 | 2.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.1 | 7.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
1.1 | 4.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.1 | 3.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.0 | 2.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
1.0 | 6.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 15.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.9 | 30.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 7.4 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.9 | 16.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.8 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.8 | 56.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 4.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 13.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.8 | 14.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.8 | 9.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.7 | 7.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 12.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 7.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 7.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.7 | 19.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 6.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 4.4 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 37.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.5 | 0.5 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.5 | 2.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 9.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.4 | 67.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 2.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 14.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 6.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 4.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |